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ABSTRACT 
Orthogonally protected polyamines (PAs) have been synthesized using α,ω-
diamines and ω-aminoalcohols as N-Cx-N and N-Cy synthons, respectively, and the 
Mitsunobou reaction as the key reaction for the assembly of the PA skeleta. The Trt, 
Dde and Phth groups have been employed for protecting the primary amino func-
tions and the Ns group for activating the primary amino functions towards alkyla-
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tion and secondary amino function protection. The approach has been readily ex-
tended to accommodate the total synthesis of the spider toxins Agel 416 and HO-
416b incorporating the 3-4-3-3 and the 3-3-3-4 PA skeleton, respectively. 
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INTRODUCTION 
Polymethylene polyamines (PAs), such as putrescine (Put), spermidine (Spd) 
and spermine (Spm), are naturally occurring small molecules found in all leaving 
organisms, either in their free polycationic form or conjugated to other biomole-
cules, and show interesting biological activities.1-5 Less common PAs, such as the 
nor (Nsd and Nsm) and homo (Hsd and Hsm) analogs of Spd  (a 3-4 PA) and Spm 
(a 3-4-3 PA) as well isomeric PAs, such as thermospermine (Tsm, a 3-3-4 PA) 
(Figure 1), are usually found in plant cells,6-8 although the latter was first isolated 
from the extreme thermophile Thermus thermophilus.9 Due to their biological sig-
nificance and the fact that PAs could form the basis for the development of pharma-
ceuticals,10,11 there is a constant interest in the synthesis of PA analogs and conju-
gates. Interestingly, a variety of conjugates of PAs with other biomolecules (herein 
abbreviated as PACs) with notable biological activities, e.g. PACs from spiders and 
wasps, bear the other biomolecule on one of the terminal amino functions of the PA 
skeleton.2,3 This imposes interesting synthetic challenges in particular when the PA 
skeleton is not symmetrical, as it is the case with the PAs Spd and Tsm.  
The synthesis of PA analogs and conjugates has followed two traditional 
pathways. The first one involves the selective direct or indirect functionalization of 
the desired amino function(s) of a PA skeleton and the second one the assembly of 
the PA skeleton from readily available fragments bearing suitable functionalized or 
protected amino functionalities.2,3,12-19  We were recently interested in the selective 
mono-functionalization of the unsymmetrical Tsm and we therefore decided to at-
tempt the synthesis of orthogonally protected Tsm using the fragment synthesis pro-
tocol. It should be noted that mono-functionalization of the symmetrical PA Spm 
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has been effected by using the N1,N4,N8-Boc3-Spm obtained via the low temperature 
selective mono-trifluoroacetylation of Spm.20 Tsm has been first prepared by 
Ganem et al from Spd through a five-steps sequence.21 Quite recently, the fragment 
synthesis of Tsm as well as Spm and Nsm was reported on a polymer support of the 
o-chlorotrityl-type and using the nosyl (Ns) protecting group for amino protection 
and activation and the base induced alkylation of the N-nosylated amines by suita-
ble halides as the key-step for the assembly of the skeleton.22 The Mitsunobu reac-
tion has been also indicated by the same research group as an alternative for the al-
kylation of Ns-activated amines with alcohols23,24 and was used on a solid support 
for the synthesis of the spider toxin Agel 416.25  
Based on our long-standing experience in the use of the triphenylmethyl 
(trityl, Trt) group for the protection of amino functions of PAs, we reasoned that the 
Tsm skeleton incorporating orthogonally protected amino functionalities (7) could 
be assembled from readily available N-tritylated building blocks like the N-trityl-γ-
aminobutyric acid (Trt-GABA) or N-tritylputrescine (Trt-Put, 9) as N-C4 and N-C4-
N synthons, respectively, and either 1,3-diaminopropane (Dap) or the corresponding 
Dde-protected 3-aminopropanol (10a)25 as N-C3-N or N-C3 synthons, respectively. 
The Trt group, as an amino protecting group, offers a number of advantages due to 
its high lipophilicity, electron-releasing property, and steric bulk as well as its labil-
ity to mild acids. In particular, the lipophilicity of the Trt group facilitates aqueous 
work-up procedures for N-tritylated PAs and derivatives and their subsequent puri-
fication by routine flash column chromatography (FCC).  
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Figure 1. Structures of compounds and protecting groups encountered in this work. 
 
On the other hand, the 1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl (Dde) 
group, used to protect selectively primary amino functions, is stable to acids and 
bases but is readily removed by a 2% solution of hydrazine in DMF at room tem-
perature.26 Finally, the Ns group was used for N-protection and N-activation and the 
Mitsunobu reaction for the assembly of the skeleton. The successful application of 
this methodology for the preparation of Tsm derivative 7 lead us to extent it, with 
some minor modifications, to the preparation of the orthogonally protected PA de-
rivatives 1-6 depicted in Figure 1. Furthermore, the applicability of the tetra-amine 
derivatives 4-7 to the synthesis of PACs was exemplified with another syntheses of 
the spider toxins Agel 41625 and HO-416b,27 using the derivatives 4 of Spm and 5 of 
Nsm as key-intermediates, respectively.  
 
RESULTS AND DISCUSSION 
We have reported in 2012 that N-tritylation of GABA, followed by coupling 
with Dap and finally LiAlH4-mediated reduction, leads to N8-tritylspermidine (12) 
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in 52% overall yield.28 Treatment of 12 with NsCl in the presence of diisopropyl 
ethylamine (DIPEA) produced the fully protected Spd derivative 13 in 55% yield 
which was then alkylated with the Dde-protected 3-aminopropanol (10a), in the 
presence of diisopropyl azodicarboxylate (DIAD) and triphenylphosphine (TPP), to 
give the orthogonally protected Tsm (3-3-4) derivative 7 in 84% yield (Scheme 1). 
Alternatively, compound 7 could be synthesized from Put as follows. Put was 
monotritylated according to a published procedure to provide N1-tritylputrescine 
(Trt-Put, 9) in 85% yield.29 This compound was subsequently nosylated to give the 
fully protected Put derivative 14 in 88% yield. Mitsunobu reaction of compound 14 
with alcohol 10a produced the orthogonally protected Spd derivative 1a. Because 
this compound was co-eluted with the by-product iPrO2CNH-NHCO2iPr (DIADH2), 
it was used as such into the next step. Selective removal of the Dde group with 2% 
H2NNH2 in DMF, followed by nosylation and a second Mitsunobu reaction with the 
same alcohol finally provided the expected Tsm derivative 7 in 66% yield for the 
last three steps (Scheme 1). All intermediates and final products were purified by 
routine FCC. 
We envisaged that intermediate 14 could be also useful for the preparation of 
the corresponding orthogonally protected Hsd (4-4) and Hsm (4-4-4) derivatives 
with a minor modification. Because the Dde protected 4-aminobutan-1-ol (10b) 
does not efficiently condense with N-nosylated functionalities under Mitsunobu re-
action conditions (see below), we used instead the corresponding N-phthalyl pro-
tected 4-aminobutanol (11) as an N-C4 synthon. That way, the expected orthogonal-
ly protected Hsd derivative 3 was obtained in 80% yield. From this intermediate, the 
Phth group was selectively removed with H2NNH2 in refluxing EtOH, the primary 
amino function thus exposed was nosylated and the resulting new intermediate 15 
was finally condensed with a second molecule of compound 11 to give access to the 
orthogonally protected Hsm derivative 6 in 65% yield for the last three steps. Com-
pound 6 contained DIADH2 in the ratio 1:0.25 (see experimental). 
 
Scheme 1. Synthesis of orthogonally protected Spd (1a), Tsm (7), Hsd (3) and 
Hsm (6)α 
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αReagents and conditions: (i) (a) Me3SiCl, (b) Et3N, TrtCl, (c) MeOH, 
CH2Cl2/MeCN (5:1), 85%; (ii) Dap, PyBrOP, CH2Cl2, 0 ºC, 30 min, 81%; (iii) 
LiAlH4, THF, 66 ºC, overnight, 75%; (iv) NsCl, DIPEA or Et3N, CH2Cl2, 0 ºC for 
30 min then 25 ºC for 2 h, 55%-90%; (v) TPP, DIAD, THF, 25 ºC, overnight, 77%-
84%; (vi) TrtCl, CH2Cl2, 25 ºC, 2 h, 85%; (vii) 2% H2NNH2 in DMF, 25 ºC, 30 
min, 87%; (viii) TPP, DIAD, THF, 25ºC-40ºC, overnight, 87%; (ix) H2NNH2, 
EtOH, 78 ºC, 2 h, 93%.       
 
On the other hand, N-tritylation of 1,3-diaminopropane (Dap) in the way de-
scribed for Trt-Put provided the N1-tritylamino-3-aminopropane (Trt-Dap, 8) in 
85% yield. This compound was nosylated and the thus obtained fully protected Dap 
derivative 16 was condensed with alcohol 10a under Mitsunobu reaction conditions 
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to give the orthogonally protected Nsd derivative 2 in 74% overall yield (Scheme 
2). Dde removal and subsequent nosylation of the resulting primary amino function 
provided the dinosylated intermediate 17 in 60% yield. This was then reacted with a 
second molecule of alcohol 10a in the presence of DIAD and TPP to provide the 
orthogonally protected Nsm derivative 5. Due to the co-elution of derivative 5 with 
DIADH2, alkylation of intermediate 17 with bromide 10c was alternatively used. 
Nevertheless, derivative 5 containing DIADH2 can be subjected to removal of the 
Dde group, as the thus obtained partially deprotected PA derivative can be obtained 
free of DIADH2 by routine FCC (see below). 
 
Scheme 2. Synthesis of orthogonally protected Spd (1b), Spm (4), Nsd (2) and 
Nsm (5) α 
 
αReagents and conditions: (i) TrtCl, CH2Cl2, 25 ºC, 2 h, 85%; (ii) NsCl, Et3N, 
CH2Cl2, 0 ºC for 30 min then 25 ºC for 2 h, 66-84%; (iii) TPP, DIAD, THF, 25 ºC, 
overnight, 89%; (iv) 2% H2NNH2 in DMF, 25 ºC, 30 min, 72%; (v) TPP, DIAD, 
THF, 25 ºC-40 ºC, overnight, 82%; (vi) H2NNH2, EtOH, 78 ºC, 2 h, 94%; (vii) 
K2CO3, DMF, 60 ºC, 2.5 h, 76-88%. 
 
Compound 16 was also considered as a key-intermediate for the step-wise as-
sembly of the Spm skeleton. However, attempted Mitsunobu reaction of compound 
16 with alcohol 10b25 was sluggish and produced the expected Spd derivative in 
only 25% even after repeated additions of alcohol, DIAD and TPP. Τherefore,we 
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decided to use the corresponding 4-phthalimidobutan-1-ol (11), which cannot un-
dergo intramolecular alkylation, instead of alcohol 10b. Indeed, using compound 11 
as the alcohol component in the Mitsunobu reaction with intermediate 16, we ob-
tained the expected orthogonally protected Spd derivative 1b in 82% yield (Scheme 
2). Selective Phth-group removal and nosylation of the unmasked primary amino 
function produced the dinosylated intermediate 18 in 62% yield. Coupling com-
pound of 18 with alcohol 10a in the presence of DIAD and TPP produced the or-
thogonally protected Spm derivative 4. This compound co-eluted with DIADH2 and 
the side-product iPrO2CNH-N(R)CO2iPr, where R is the alkyl group of alcohol 10a. 
However, selective removal of the Dde group produces N4,N9-dinosyl-N1-
tritylspermine which can be readily purified and actually was used in the synthesis 
of toxin Agel-416 (see Scheme 4). Alternatively, the pure orthogonally protected 
Spm derivative 4 can be prepared in 88% yield by alkylation of intermediate 18 
with bromide 10c. 
The applicability of the orthogonally protected PA derivatives 1-7 to the syn-
thesis of PACs was exemplified with alternative syntheses of spider toxin HO-416b 
(a 4-3-3-3 PAC) using the Nsm derivative 5 (a 3-3-3 PA derivative) as key-
intermediate and the spider toxin Agel 416 (a 3-3-4-3 PAC) using the Spm deriva-
tive 4 (a 3-4-3 PA derivative) as key-intermediate. These syntheses could be effect-
ed by either a convergent or a linear way. We used the former way in the synthesis 
of the HO-416b toxin and the latter in the synthesis of the Agel 416 toxin.  
Accordingly, activation of (indol-3-yl)acetic acid (IAA, 20a) with N-
hydroxysuccinimide (HOSu) and N,N’-dicyclohexylcarbodiimide (DCC) and cou-
pling with 4-aminobutanol provided the N-(4-hydroxybutyl)-2-(1H-indol-3-
yl)acetamide (21a) in 65% yield. On the other hand Dde deprotection of intermedi-
ate 5, followed by nosylation, gave the trinosylated Nsm derivative 22 in 76% yield 
(Scheme 3). Unfortunately, alcohol 21a could not be coupled directly with com-
pound 22 under Mitsunobu reaction conditions obviously due to the unprotected NH 
function of the indole nucleus. We therefore decided to protect the NH functionality 
of IAA (20a) with the acid-labile tert-butoxycarbonyl (Boc) group prior to coupling 
with 4-aminobutanol. Attempted introduction of the Boc group in IAA (20a) in a 
manner similar to the one-pot sequence described by our research group for the syn-
thesis N-tritylamino acids,30 involving silylation of the carboxyl function, tert-
butoxycarbonylation in the presence of 4-dimethylaminopyridine (DMAP) and fi-
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nally methanolysis of the resulting silyl ester, failed to produce the expected Nind-
Boc-IAA (20b). 
 
Scheme 3. Synthesis of the spider toxin HO-416b. α 
 
 
 
αReagents and conditions: (i) (a) HOSu, DCC (b) 4-aminobutanol, DMF, 25 ºC, 2 h, 
65-72%; (ii) (a) PhCOCH2Br, Et3N, DMF, 0 ºC for 30 min then 25 ºC for 2 h, 81%, 
(b) Boc2O, Et3N, DMAP, CH2Cl2, 25 ºC, 3 h, 91%, (c) PhSH, Na2CO3, DMF, 60 ºC, 
2 h, 84%; (iii) (a) 2% H2NNH2 in DMF, 25 ºC, 30 min, 94%, (b) NsCl, Et3N, 
CH2Cl2, 0 ºC for 30 min then 25 ºC for 1.5 h, 81%; (iv) TPP, DIAD, THF, 40 ºC, 
overnight; (v) PhSH, Na2CO3, DMF, 25 ºC, overnight; (vi) 10% TFA in CH2Cl2 and 
PhSH, 25 ºC, 1 h, 70%.  
 
 Literature procedures for the preparation of Nind-Boc-IAA (20b) use a three-
steps sequence, involving protection of the carboxyl function as an isolable methyl25 
or allyl31 ester, followed by reaction with Boc2O in the presence of DMAP and fi-
nally carboxyl group deprotection. We used instead the phenacyl group for the pro-
tection of the carboxyl function of IAA (20a). Thus, reaction of IAA (20a) with 
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phenacyl bromide in the presence of Et3N produced the corresponding phenacyl es-
ter in 81% yield. Reaction of this ester with Boc2O in the presence of DMAP and 
Et3N resulted in N-protection and the thus obtained, in 91% yield, fully protected 
IAA was treated with thiophenol and Na2CO3 to produce Nind-Boc-IAA (20b) in 
84% yield. Activation of the thus obtained acid Nind-Boc-IAA (20b) with HOSu and 
DCC and coupling with 4-aminobutanol produced the Nind-Boc protected alcohol 
21b in 72% yield. This alcohol was then coupled directly with the trinosylated Nsm 
derivative 22 under Mitsunobu reaction conditions to give the expected fully pro-
tected crude HO-416b (23a) which contained triphenylphosphine oxide (TPPO), 
DIADH2 and a side-product iPrO2CNH-N(R')CO2iPr, where R' is the alkyl group of 
alcohol 21b. Treatment of crude intermediate 23a with PhSH and Na2CO3 in DMF 
resulted in the deprotection of the three secondary amino functions to give pure in-
termediate 23b in 57% yield for the last two steps. From this compound, toxin HO-
416b was readily obtained, as the corresponding penta-trifluoroacetate salt, in 70% 
yield and 97% purity according to HPLC analysis, upon deprotection with 10% tri-
fluoroacetic acid (TFA) in CH2Cl2 in the presence of the cation scavenger PhSH. 
For the synthesis of the Agel 416 toxin we decided to explore the viability of 
the linear way, which involves first the extension of the PA chain of Spm to the de-
sired length. Thus, the Dde protecting group of Spm derivative 4 was selectively 
removed with 2% H2NNH2 in DMF and the resulting free primary amino function 
was nosylated to give the trinosylated Spm derivative 25 in 80%. This intermediate 
was then directly coupled with alcohol 10a under Mitsunobu reaction conditions to 
produce the fully protected pentaamine 26a which co-eluted with TPPO. The thus 
obtained crude 26a was subjected to Dde group removal to give pure N4,N8,N13-
trinosyl-N16-trityl-4,8,13-triazahexadeka-1,16-diamine following routine FCC. Al-
ternatively, derivative 25 was alkylated with bromide 10c to provide pure interme-
diate 26a in 72% yield. From this intermediate, the Dde group was selectively re-
moved and the resulting free primary amino function was acylated with IAA (20a), 
which had been preactivated with HOSu and N,N’-diisopropylcarbodiimide (DIC). 
That way, the partially protected Agel 416 (27a) was obtained, containing N,N’-
diisopropylurea (DICU). Crude intermediate 27a was then selectively deprotected at 
the secondary amino functions with PhSH and Na2CO3 in DMF to give pure inter-
mediate 27b in 49% yield for the two steps. Finally, trityl group removal with 10% 
TFA in CH2Cl2 in the presence PhSH, provided the expected toxin Agel 416, as the 
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corresponding penta-trifluoroacetate salt, in 73% yield and 93% purity according to 
HPLC analysis. 
 
Scheme 4. Synthesis of the spider toxin Agel 416. α 
 
 
 
αReagents and conditions: (i) 2% H2NNH2 in DMF, 25 ºC, 30 min, 83%-91%; (ii) 
NsCl, Et3N, CH2Cl2, 0 ºC for 30 min then 25 ºC for 1.5 h, 87%; (iii) TPP, DIAD, 
THF, 25 ºC, overnight; (iv) K2CO3, DMF, 60 ºC, 2.5 h, 72%; (v) HOSu, DIC, DMF; 
(vi) PhSH, Na2CO3, DMF, 25 ºC, overnight; (vii) 10% TFA in CH2Cl2 and PhSH, 
25 ºC, 1 h, 73%.  
 
CONCLUSIONS 
  Τhe mono-N-tritylated putrescine and propane-1,3-diamine were used as N-
C4-N and N-C3-N synthons, respectively and the N-Dde or N-phthaloyl-protected 3-
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aminopropan-1-ol (or the  corresponding bromide) and 4-aminobutan-1-ol were 
used as N-C3 and N-C4 synthons, respectively, in the liquid phase fragment synthe-
sis of the naturally occurring PAs spermidine, spermine and thermospermine and 
their lower and higher homologs nor- and homo-spermidine and -spermine. Key-
figures in the assembly of PA chains in the required length were the use of the lipo-
philic trityl group, which facilitates aqueous work-up and purification by routine 
flash column chromatography, for N-protection and the nosyl group for the protec-
tion of secondary amino functions and activation of primary amino functions to-
wards alkylation with alcohols in the presence of TPP and DIAD (Mitsunobu reac-
tion) or the corresponding bromides in the presence of K2CO3.  
The resulting orthogonally protected triamines and tetra-amines are well-
suited, for example, for the preparation of unsymmetrically bisalkylated PA analogs 
and for the selective monoacylation of  PAs, in particular asymmetric ones, leading 
to biologically interesting PACs. In addition, they can be extended to any direction 
by the selective removal of any of the protecting groups giving rise to higher order 
PAs. This extension may also provide access to a series of PA conjugates, such as 
the PA-type toxins from spiders and wasps. Indeed, this possibility was exemplified 
in the present work with alternative syntheses of the spider toxins Agel 416 and 
HO-416b, incorporating a pentaamine skeleton (3-4-3-3 and 3-3-3-4, respectively) 
and the lipophilic carboxylic acid IAA (20a). From the two alternative routes exam-
ined, the convergent one involving acylation of the ω-aminoalcohol with the in situ 
generated succinimidyl ester of N-Boc-protected IAA, followed by a Mitsunobu re-
action gave purer final product than the linear one, involving first extension of the 
PA chain using the Mitsunobu reaction, followed by coupling with the succinimidyl 
ester of unprotected IAA. Both syntheses were finalized by routine PhSNa-mediated 
removal of the Ns groups, followed by TFA-mediated acidolysis of Boc and/or Trt 
groups. The present methodology can be also applied to the synthesis of a variety of 
PA analogs and PACs with changes in the aliphatic region of the PA skeleton by 
selecting the required α,ω-diaminoalkanes and ω-aminoalcohols, as N-Cn-N and N-
Cn synthons, respectively. We are currently investigating the application of the pre-
sent methodology to the synthesis of other PA analogs and conjugates and their bio-
logical evaluation as potential anticancer agents. 
 
EXPERIMENTAL SECTION 
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General information. Melting points were determined with an Electrothermal 
apparatus and are uncorrected. 1H-NMR and 13C-NMR spectra were obtained at 600 
and 150 MHz, respectively, on Bruker AvanceIII HD spectrometer. Chemical shifts 
(δ) are reported for CDCl3 solutions in parts per million (ppm) downfield from tet-
ramethylsilane (TMS), used as internal standard, or for (CD3)2SO solutions.  
The HRMS-analysis for oily or foamy samples, using LC-MS grade MeOH as 
solvent, was performed using an ESI-LTQ-ORBITRAP XL unit (Thermo Scientific, 
Bremen, Germany). The Orbitrap Unit was operated in positive mode, with a spray 
voltage of 3.2 kV, while the sheath gas (N2) flow rate and auxiliary gas (N2) flow 
rate were adjusted to 12 and 2 arbitrary units, respectively. The capillary voltage 
and the tube lens voltage were set to 10 and 110 V, respectively. The scan ranged 
from m/z 150 up to 2000.  Electron-spray ionization (ESI) mass spectra were rec-
orded at 30 eV, on a Waters Micromass ZQ spectrometer using HPLC grade MeOH 
or MeCN as solvent, or MeCN/H2O as solvent system.  
Analytical reversed phase high-performance liquid chromatography was per-
formed on Agilent Technologies, 1260 Affinity, Quaternary Pump VL system 
equipped with a photodiode array detector. The purity of the final conjugates was 
determined using UV detection (λ=254 nm). The chromatographic method em-
ployed the following: column, LeChrosorb RP18 (25 cm x 4.6 mm, 5 μm); mobile 
phase I, 0.08% TFA in water; mobile phase II, acetonitrile with 0.08% TFA; flow 
rate, 1.0 mL/min; elution profile, gradient elution from 5 to 50% II over 30 min. El-
emental analyses for solid compounds were determined on a Carlo Erba EA 1108 
CHNS elemental analyzer. 
Flash column chromatography (FCC) was performed on Acros Organics silica 
gel 0.035-0.070 mm, 60 Å and TLC on Merck silica gel 60 F254 films (0.2 mm) pre-
coated on aluminium foil. Spots were visualized with UV light at 254 nm and by 
spraying with a ninhydrine solution (0.3 g ninhydrin, 3 mL gl. acetic acid, 97 mL 1-
butanol). The solvent systems used for the development of TLC or FCC are the fol-
lowing: (A) CHCl3/MeOH (98:2), (B) CHCl3/MeOH (95:5), (C) CHCl3/MeOH 
(9:1), (D) CHCl3/MeOH/NH3 (99:1:0.1), (E) CHCl3/MeOH/NH3 (98:2:0.2), (F) 
CHCl3/MeOH/NH3 (97:3:0.3), (G) CHCl3/MeOH/NH3 (95:5:0.5), (H) 
CHCl3/MeOH/NH3 (9:1:0.1), (I) CHCl3/MeOH/NH3 (8.5:1.5:0.15), (J) 
CHCl3/MeOH/NH3 (8:2:0.2), (K) CHCl3/MeOH/NH3 (7:3:0.3), (L) 
CHCl3/MeOH/NH3 (6:4:0.4), (M) PhMe/EtOAc (93:7), (N) PhMe/EtOAc (9:1), (O) 
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PhMe/EtOAc (8:2), (P) PhMe/EtOAc (7:3), (Q) PhMe/EtOAc (6:4), (R) 
PhMe/EtOAc (1:1), (S) EtOAc/PhMe (7:3), (T) EtOAc/PhMe (8:2), (U) Hex/EtOAc 
(8:2), (V) Hex/EtOAc (7:3), (W) Hex/EtOAc (1:1). 
All solvents were dried and/or purified according to standard procedures prior 
to use. Solvents were routinely removed at ca. 40 ºC under reduced pressure on 
Bücki Rotavapor RE 111 apparatus. Air-sensitive reagents were handled under inert 
atmosphere (Ar). All reagents employed in the present work were purchased from 
either Sigma-Aldrich or Alfa Aesar or Merck or Acros Organics or Fluorochem and 
were used without further purification. DIAD was used in the context of this work 
as a commercially available safer alternative to DEAD.  
For the needs of the present work, the N8-tritylspermidine (12) was prepared 
according to a published procedure.28  
 
 General procedure for the preparation of N1-tritylated diamines 
The N1-tritylputrescine (Τrt-Put, 9) was prepared according to a published proce-
dure.29 Using identical procedure, the preparation of N1-trityl-1,3-diaminopropane 
(Trt-Dap, 8) was realized.  
 
N1-Trityl-1,3-diaminopropane (8). Colorless oil (1.29 g, 85%); Rf (G): 0.32; 1H 
NMR (600 MHz, CDCl3) δ 7.47 (d, J = 7.2 Hz, 6H), 7.27 (t, J = 7.2 Hz, 6H), 7.18 
(t, J = 7.2 Hz, 3H), 2.78 (t, J = 6.6 Hz, 2H), 2.20 (t, J = 6.6 Hz, 2H), 1.63 (quint., J 
= 6.6 Hz, 2H), 1.46 (br. s, 3H) ppm; 13C{1H} NMR (150 MHz, CDCl3) δ 146.1 
(3C), 128.6 (6C), 127.8 (6C), 126.2 (3C), 70.9, 41.4, 40.6, 34.7 ppm; MS (ESI, 30 
eV): m/z 317.11 [M+H]+, 243.17 [Trt]+.  
 
General procedure for the protection of ω-aminoalcohols with the Dde 
group 
In general, the procedure described in the literature25 was employed for the N-
protection of 3-aminopropan-1-ol and 4-aminobutan-1-ol with the Dde group as fol-
lows: 
To a stirred solution of Dde-OH (1.36 g, 7.46 mmol) in EtOH (3 mL), the ω-
aminoalkanol (7.46 mmol) was added. The resulting mixture was heated under re-
flux for 30 min. Then it was left to attain room temperature and the solvent was 
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evaporated under reduced pressure to leave a crystalline residue. Recrystallisation 
from EtOAc gave the expected N-protected compound.  
 
N-1-(4,4-Dimethyl-2,6-dioxocyclohexylidene)ethyl-3-aminopropan-1-ol (10a). 
White crystals (1.55 g, 87%); mp 106-108 oC; Rf (B): 0.21; 1H NMR (600 MHz, 
CDCl3) δ 13.45 (br. s, 1H), 3.78 (t, J = 6 Hz, 2H), 3.56 (q, J = 6 Hz, 2H), 2.57 (s, 
3H), 2.35 (s, 4H), 2.00 (br. s, 1H), 1.92 (quint., J = 6 Hz, 2H), 1.02 (s, 6H) ppm; 
13C{1H} NMR (150 MHz, CDCl3) δ 197.8 (2C), 173.7, 107.9, 59.4, 52.9 (2C), 40.2 
(2C), 31.6, 30.1 (2C), 28.3 (2C), 17.9 ppm; MS (ESI, 30 eV): m/z 517.44 [2M+K]+, 
262.48 [M+Na]+, 240.52 [M+H]+.  
 
N-1-(4,4-Dimethyl-2,6-dioxocyclohexylidene)ethyl-4-aminobutan-1-ol (10b). 
Beige crystals (1.15 g, 91%); mp 105-107 oC; Rf (B): 0.35; 1H NMR (600 MHz, 
CHCl3) δ 13.45 (br. s, 1H), 3.70 (t, J = 6 Hz, 2H), 3.45 (q, J = 6 Hz, 2H), 2.56 (s, 
3H), 2.35 (s, 4H), 1.79 (quint., J = 6 Hz, 2H), 1.74 (br. s, 1H), 1.68 (quint., J = 6 
Hz, 2H) 1.02 (s, 6H) ppm;  13C{1H} NMR (150 MHz, CDCl3) δ 197.7 (2C), 173.5, 
107.9, 62.0, 52.9 (2C), 43.3, 30.1, 29.8, 28.3 (2C), 25.7, 17.9 ppm; MS (ESI, 30 
eV): m/z 529.26 [2M+Na]+, 276.20 [M+Na]+, 254.26 [M+H]+.  
 
Preparation of 1-bromo-3-(1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl-
aminopropane (10c). 
Triphenylphosphine (0.82 g, 3.12 mmol) was added portion-wise during a period of 
2 h to a well-stirred solution of 10a (0.66 g, 2.78 mmol) and carbon tetrabromide 
(1.38 g, 4.17 mmol) in dry CH2Cl2 (1.5 mL) at room temperature. After an addition-
al 1 h of stirring the reaction mixture was applied on the top of a chromatography 
column and subjected to FCC, using EtOAc as eluant, to give bromide 10c. 
 
White solid (0.74 g, 88%); mp 63-66 oC; Rf (EtOAc): 0.41; 1H NMR (600 MHz, 
CDCl3) δ 13.56 (br. s, 1H), 3.60 (q, J = 6.6 Hz, 2H), 3.49 (t, J = 6.6 Hz, 2H), 2.59 
(s, 3H), 2.37 (s, 4H), 2.21 (quint., J = 6.6 Hz, 2H), 1.03 (s, 6H) ppm;  13C{1Η} NMR 
(150 MHz, CDCl3) δ 198.3 (2C), 173.9, 108.1, 52.9 (2C), 41.4, 31.7, 30.1, 29.5, 
28.3 (2C), 17.8 ppm; Anal. Calcd (%) for C13H20BrNO2: C, 51.67; H, 6.67; N, 4.63. 
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Found: C, 51.87; H, 6.55; N, 4.48; MS (ESI, 30 eV): m/z 326.48 and 324.44 
[M+Na]+, 304.49 and 302.45 [M+Η]+. 
 
Preparation of 4-phthalimidobutan-1-ol (11). 
A solution of 4-aminobutan-1-ol (0.5 mL, 5.5 mmol) in THF (2.5 mL) was added 
during a period of 20 min to a stirred slurry of N-(ethoxycarbonyl)phthalimide (1.1 
g, 5 mmol) in THF (2.5 mL) at 0 oC. The mixture was further stirred for 2 h at room 
temperature. The completion of reaction was confirmed by TLC, using solvent sys-
tem R. After removal of the solvent under reduced pressure, the residue diluted with 
CH2Cl2 and washed twice with H2O and once with brine. The organic layer was 
dried over Na2SO4 and evaporated to dryness to leave a thick oil. Even after purifi-
cation with FCC, using solvent system R for elution, the product 11 was found (by 
1ΝΜR) to contain ethyl carbamate in the molar ratio 11:ethyl carbamate = 1.4:1 and 
used as such into the following alkylation reactions. 
 
Thick colorless oil (0.81 g, 67%); Rf (R): 0.30; 1H NMR (600 MHz, CDCl3) δ 7.84-
7.83 (m, 2H), 7.72-7.70 (m, 2H), 3.74 (t, J = 7.2 Hz, 2H), 3.69 (t, J = 7.2 Hz, 2H), 
1.97 (br. s, 1H), 1.78 (quint., J = 7.2 Hz, 2H), 1.62 (quint., J = 7.2 Hz, 2H) ppm; 
13C{1H} NMR (150 MHz, CDCl3) δ 168.5 (2C), 133.9 (2C), 132.2 (2C), 123.2 (2C), 
62.2, 37.7, 29.8, 25.1 ppm. 
 
General procedure for the nosylation of N-tritylated polyamines  
A typical procedure for the mononosylation of N-tritylated PAs is the following: To 
an ice-cold solution of N1-tritylputrescine (9) (1.18 g, 3.50 mmol) in dry CH2Cl2 (14 
mL) and Et3N (1.1 mL, 7.4 mmol), 2-nitrobenzenesulfonyl chloride (0.82 g, 3.70 
mmol) was added portion-wise over 1.5 h under an inert atmosphere. The mixture 
was kept at 0 oC for further 30 min and then allowed to attain room temperature. 
The completion of the reaction was confirmed by TLC using the solvent system H. 
The reaction mixture was then diluted with CH2Cl2 and washed twice with 5% 
aqueous solution of Na2CO3, twice with H2O and once with brine. The organic layer 
was dried over Na2SO4 and evaporated to dryness. The product 14 was obtained 
pure following FCC purification using solvent system N for elution. 
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In the case of the preparation of N1,N4-dinosyl-N8-tritylspermidine (13) from N8-
tritylspermidine (12) were double nosylation was required, 4.4 equiv of  DIPEA and 
2.2 equiv of NsCl were employed.  
  
N1,N4-Dinosyl-N8-tritylspermidine (13). Reaction time: 2 h; slightly yellow oil (0.15 
g, 55%); Rf (O): 0.28; 1H NMR (600 MHz, CDCl3) δ 8.11-8.09 (m, 1H), 7.98 (dd, J 
= 7.8 and 1.2 Hz, 1H), 7.85-7.83 (m, 1H), 7.73-7.69 and 7.69-7.63 (two m, 4H), 
7.60 (dd, J = 7.2 and 1.2 Hz, 1H), 7.44-7.41 (m, 6H), 7.29-7.23 (m, 6H), 7.20-7.15 
(m, 3H), 5.59 (unresolv. t, 1H), 3.36 (t, J = 6.6 Hz, 2H), 3.24 (t, J = 7.2 Hz, 2H), 
3.16 (q, J = 6.6 Hz, 2H), 2.07 (unresolv. t, 1H), 1.82 (quint., J = 6.6 Hz, 2H), 1.53 
(quint., J = 7.2 Hz, 4H), 1.40 (quint., J = 7.2 Hz, 2H) ppm; 13C{1H} NMR (150 
MHz, CDCl3) δ 148.1, 148.0, 146.1 (3C), 133.7, 133.6, 133.5, 133.2, 132.8, 131.8, 
131.0, 130.9, 128.6 (6C), 127.8 (6C), 126.3 (3C), 125.3, 124.2, 70.8, 47.9, 44.7, 
43.1, 40.7, 28.9, 27.8, 26.2 ppm; HRMS (Orbitrap-ESI) m/z calcd for C38H40N5O8S2 
[M+ H]+ 758.2318, found 758.2335. 
 
N1-Nosyl-N4-tritylputrescine (14). Reaction time: 2 h; slightly yellow solid; (1.59 g, 
88%); mp 149-152 oC; Rf (N): 0.36; 1H NMR (600 MHz, CDCl3) δ 8.14-8.10 (m, 
1H), 7.87-7.83 (m, 1H), 7.74-7.70 (m, 2H), 7.44-7.41 (m, 6H), 7.28-7.24 (m, 6H), 
7.20-7.16 (m, 3H), 5.29 (t, J = 6.6 Hz, 1H), 3.08 (q, J = 6.6 Hz, 2H), 2.11 (t, J = 6.6 
Hz, 2H) 1.61 (quint., J = 6.6 Hz, 2H), 1.55 (br. s, 1H), 1.48 (quint., J = 6.6 Hz, 2H) 
ppm; 13C{1H} NMR (150 MHz, CDCl3) δ 148.1, 146.0 (3C), 133.9, 133.5, 132.7, 
131.1, 128.6 (6C), 127.8 (6C), 126.3 (3C), 125.4, 70.9, 43.9, 43.0, 27.8, 27.6 ppm; 
Anal. Calcd (%) for C29H29N3O4S: C, 67.55; H, 5.67; N, 8.15. Found: C, 67.84; H, 
5.38; N, 8.09; MS (ESI, 30 eV): m/z 554.47 [M+K]+, 538.60 [M+Na]+, 516.62 
[M+H]+, 243.66 [Trt]+. 
 
N1,N5-Dinosyl-N9-tritylhomospermidine (15). Reaction time: 2 h; yellow oil (0.3 g, 
80%); Rf (O): 0.35; 1H NMR (600 MHz, CDCl3) δ 8.12-8.10 (m, 1H), 7.96 (d, J = 
7.8 Hz, 1H), 7.85-7.82 (m, 1H), 7.74-7.71 (m, 2H), 7.69-7.62 (m, 2H), 7.59 (d, J = 
7.8 Hz, 1H), 7.45-7.41 (m, 6H), 7.29-7.24 (m, 6H), 7.20-7.16 (m, 3H), 5.27 (t, J = 6 
Hz, 1H), 3.28 (t, J = 7.2 Hz, 2H), 3.24 (t, J = 6 Hz, 2H), 3.10 (q, J = 6 Hz, 2H), 2.09 
(t, J = 6.9 Hz, 2H), 1.61-1.51 (m, 7H), 1.42 (quint., J = 6.9 Hz, 2H) ppm; 13C{1H} 
NMR (150 MHz, CDCl3) δ 148.1, 148.0, 146.1 (3C), 133.63, 133.59, 133.57, 133.5, 
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132.9, 131.7, 131.1, 130.7, 128.6 (6C), 127.8 (6C), 126.3 (3C), 125.4, 124.2, 70.8, 
47.3, 46.5, 43.12, 43.09, 27.8, 26.6, 26.0, 25.0 ppm; HRMS (Orbitrap-ESI) m/z 
calcd for C39H42N5O8S2 [M+H]+ 772.2475, found 772.2439. 
 
N1-Nosyl-N3-trityl-1,3-diaminopropane (16). Reaction time: 2 h; Slightly yellow 
solid (1.89 g, 83%); mp 185-189 oC; Rf (O): 0.29; 1H NMR (600 MHz, CDCl3) δ 
8.15-8.11 (m, 1H), 7.84-7.80 (m, 1H), 7.75-7.69 (m, 2H), 7.44-7.40 (m, 6H), 7.29-
7.24 (m, 6H), 7.21-7.16 (m, 3H), 5.72 (br. s, 1H), 3.26 (t, J = 6.6 Hz, 2H), 2.19 (t, J 
= 6.6 Hz, 2H), 1.68 (quint., J = 6.6 Hz, 2H), 1.55 (br. s, 1H) ppm; 13C{1H} NMR 
(150 MHz, CDCl3) δ 148.1, 145.7 (3C), 133.9, 133.4, 132.6, 131.1, 128.6 (6C), 
127.9 (6C), 126.6 (3C), 125.3, 71.1, 42.6, 41.4, 30.6 ppm; Anal. Calcd (%) for 
C28H27N3O4S: C, 67.05; H, 5.43; N, 8.38. Found: C, 66.85; H, 5.58; N, 8.64; MS 
(ESI, 30 eV): m/z 540.57 [M+K]+, 524.45 [M+Na]+, 243.59 [Trt]+. 
 
N1,N4-Dinosyl-N7-tritylnorspermidine (17). Reaction time: 2 h; Pale yellow solid 
(1.62 g, 84%); mp 166.0-168.4 oC; Rf (N): 0.25; 1H NMR (600 MHz, CDCl3) δ 8.11 
(dd, J = 7.2 and 1.7 Hz, 1H), 7.99 (dd, J = 7.8 and 0.9 Hz, 1H), 7.84 (dd, J = 7.2 and 
1.7 Hz, 1H), 7.75-7.70 and 7.70-7.63 (two m, 4H), 7.59 (dd, J = 7.2 and 0.7 Hz, 
1H), 7.43-7.39 (m, 6H), 7.28-7.24 (m, 6H), 7.20-7.16 (m, 3H), 5.60 (unresolv. t, 
1H), 3.39-3.34 (m, 4H), 3.14 (q, J = 6.6 Hz, 2H), 2.08 (unresolv. t, 2H), 1.81 
(quint., J = 6.6 Hz, 2H), 1.66 (unresolv. quint., 2H), 1.55 (br. s, 1H) ppm; 13C{1H} 
NMR (150 MHz, CDCl3) δ 148.1, 148.0, 145.8 (3C), 133.7, 133.63, 133.60, 133.0, 
132.8, 131.7, 130.90, 130.89, 128.6 (6C), 127.9 (6C), 126.4 (3C), 125.5, 124.3, 
70.9, 46.2, 44.8, 40.9, 40.6, 29.6, 29.0 ppm; Anal. Calcd for C37H37N5O8S2: C, 
59.74; H, 5.01; N, 9.42. Found: C, 59.93; H, 4.89; N, 9.21; MS (ESI, 30 eV): m/z 
782.42 [M+K]+, 766.31 [M+Na]+, 744.60 [M+H]+, 243.54 [Trt]+. 
 
N4,N8-Dinosyl-N1-tritylspermidine (18). Reaction time: 2 h; Pale yellow solid (0.86 
g, 66%); mp 178-181 oC; Rf (O): 0.28; 1H NMR (600 MHz, (CD3)2SO) δ 8.08 (t, J = 
6.6 Hz, 1H), 7.99-7.96 (m, 1H), 7.96-7.92 (m, 3H), 7.88-7.85 and 7.85-7.82 (two m, 
3H), 7.79 (td, J = 7.2 and 0.9 Hz, 1H), 7.36-7.33 (m, 6H), 7.29-7.24 (m, 6H), 7.18-
7.14 (m, 3H), 3.25 (t, J = 7.2 Hz, 2H), 3.15 (t, J = 6.6 Hz, 2H), 2.87 (q, J = 6.6 Hz, 
2H), 2.65 (t, J = 7.2 Hz, 1H), 1.91 (q, J = 6.6 Hz, 2H), 1.61 (quint., J = 6.6 Hz, 2H), 
1.44 (quint., J = 6.6 Hz, 2H), 1.37 (quint., J = 7.2 Hz, 2H) ppm; 13C{1H} NMR (150 
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MHz, (CD3)2SO) δ 148.2, 148.0, 146.5 (3C), 134.8, 134.4, 133.2, 133.1, 132.8, 
132.2, 130.1, 129.9, 128.8 (6C), 128.1 (6C), 126.5 (3C), 124.8, 124.7, 70.9, 47.2, 
46.1, 42.7, 41.2, 29.2, 26.7, 25.5 ppm; Anal. Calcd for C38H39N5O8S2: C, 60.22; H, 
5.19; N, 9.24. Found: C, 60.35; H, 5.01; N, 9.1; MS (ESI, 30 eV): m/z 796.25 
[M+K]+, 780.32 [M+Na]+, 243.52 [Trt]+. 
 
N1,N4,N8-Trinosyl-N11-tritylnorspermine (22). Reaction time: 1.5 h; Yellow foam 
(1.49 g, 81%); Rf (O): 0.17; 1H NMR (600 MHz, CDCl3) δ 8.11-8.07 (m, 1H), 
8.01 (unresolv. dd, 1H), 7.97 (dd, J = 7.2 and 0.9 Hz, 1H), 7.86-7.82 (m, 1H), 
7.74-7.70 and 7.70-7.64 (two m, 6H), 7.59 (dd, J = 7.8 and 1 Hz, 1H), 7.56 (dd, J 
= 7.2 and 0.8 Hz, 1H), 7.45-7.39 (m, 6H), 7.29-7.23 (m, 6H), 7.21-7.16 (m, 3H), 
5.61 (t, J = 6.6 Hz, 1H), 3.40-3.35 (m, 4H), 3.31-3.24 (m, 4H), 3.14 (q, J = 6.6 Hz, 
2H), 2.09 (t, J = 6.6 Hz, 2H), 1.83 (quint., J = 6.6 Hz, 4H), 1.66 (quint., J = 6.6 
Hz, 2H), 1.60 (br. s, 1H) ppm; 13C{1H} NMR (150 MHz, CDCl3) δ 148.1, 148.0 
(2C), 145.9 (3C), 133.9, 133.7, 133.6, 133.5, 133.0, 132.9, 132.6, 132.1, 131.8, 
130.94, 130.92, 130.7, 128.6 (6C), 127.8 (6C), 126.3 (3C), 125.4, 124.3, 124.2, 
70.9, 46.0, 45.5, 45.2, 44.9, 40.8, 40.7, 29.3, 28.8, 27.6 ppm; HRMS (Orbitrap-
ESI) m/z calcd for C46H48N7O12S3 [M+H]+ 986.2523, found 986.2530. 
 
N1,N4,N8-Trinosyl-N12-tritylspermine (25). Reaction time: 1.5 h; Yellow foam (0.93 
g, 87%); Rf (O): 0.18; 1H NMR (600 MHz, CDCl3) δ 8.11-8.08 (m, 1H), 8.01-7.97 
(m, 2H), 7.85-7.81 (m, 1H), 7.74-7.70, 7.70-7.67 and 7.67-7.62 (three m, 6H), 7.60-
7.57 (m, 2H), 7.42-7.38 (m, 6H), 7.28-7.24 (m, 6H), 7.20-7.14 (m, 3H), 5.60 (t, J = 
6 Hz, 1H), 3.37-3.31 (m, 4H), 3.30-3.26 (m, 4H), 3.13 (q, J = 6 Hz, 2H), 2.06 (t, J = 
6 Hz, 2H), 1.83 (quint., J = 6 Hz, 2H), 1.64 (quint., J = 7.2 Hz, 2H), 1.54-1.50 (m, 
5H) ppm; 13C{1H} NMR (150 MHz, CDCl3), δ 148.1, 148.0, 147.9, 145.9 (3C), 
133.7, 133.6, 133.55, 133.50, 133.3, 132.9, 132.8, 131.9, 131.7, 1310, 130.83, 
130.80, 128.6 (6C), 127.8 (6C), 126.3 (3C), 125.4, 124.3, 124.2, 70.9, 47.3, 46.6, 
46.5, 44.8, 40.9, 40.8, 29.3, 28.8, 25.04, 24.99 ppm; HRMS (Orbitrap-ESI) m/z 
calcd for C47H50N7O12S3 [M+H]+ 1000.2680, found 1000.2568. 
 
General procedure for the Mitsunobu reaction between nosylated PAs 
and N-protected ω-aminoalcohols  
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A typical procedure for the Mitsunobu reaction of N-nosylated PAs and N-protected 
ω-aminoalcohols is the following: 
To an ice-cold solution of Spd derivative 13 (0.76 g, 1 mmol), alcohol 10a (0.31 g, 
1.30 mmol) and TPP (0.34 g, 1.30 mmol) in dry THF (2.9 mL), DIAD (0.26 mL, 
1.30 mmol) was added under an inert atmosphere. The reaction mixture was al-
lowed to attain room temperature where it was stirred for additional 2 h. The pro-
gress of the reaction was monitored by TLC using the solvent system P. Then, addi-
tional TPP (118 mg, 0.45 mmol) and DIAD (118 mg, 0.45 mmol) were added. The 
reaction mixture was further stirred for 2 h at room temperature and the completion 
of the reaction was confirmed by TLC. The solvent was evaporated and the product 
7 was obtained pure following FCC purification using EtOAc as eluant.   
The same procedure was used for the synthesis of all compounds tabulated below 
using the indicated for each case (a) different ratios of PA derivatives, alcohols, 
TPP and DIAD, (b) reaction time and (c) reaction temperature.  
  
N1-Dde-N4-nosyl-N8-tritylspermidine (1a). Quantities of reagents: 14 (1.03 g, 2.00 
mmol), 10a (0.62 g, 2.60 mmol), TPP (0.90 g, 3.33 mmol), DIAD (0.66 mL, 3.33 
mmol); Reaction time: overnight; Reaction temperature: 25 oC; Yellow oil (1.13 g, 
77%); Rf (Q): 0.18; 1H NMR (600 MHz, CDCl3) δ 13.48 (unresolv. t, 1H), 8.00 (d, J 
= 7.8 Hz, 1H), 7.67 (t, J = 7.8 Hz, 1H), 7.62 (t, J =7.8 Hz, 1H), 7.60 (d, J = 7.8 Hz, 
1H), 7.45-7.41 (m, 6H), 7.29-7.23 (m, 6H), 7.20-7.14 (m, 3H), 3.43-3.38 (m, 4H), 
3.28 (t, J = 7.5 Hz, 2H), 2.50 (s, 3H), 2.34 (s, 4H), 2.08 (t, J = 6.6 Hz, 2H), 1.92 
(quint., J = 7.5 Hz, 2H), 1.65 (br. s, 1H), 1.57 (quint., J = 6.6 Hz, 2H), 1.43 (quint., 
J = 6.6 Hz, 2H), 1.01 (s, 6H) ppm; 13C{1H} NMR (150 MHz, CDCl3) δ 173.7, 
148.0, 146.1 (3C), 133.6, 133.2, 131.7, 131.0, 128.6 (6C), 127.8 (6C), 126.3 (3C), 
124.2, 108.0, 70.8, 47.6, 44.6, 43.1, 40.6, 30.1, 28.3 (2C), 27.9, 27.8, 25.9, 17.9 
ppm; MS (ESI, 30 eV): m/z 775.22 [M+K]+, 759.47 [M+Na]+, 737.55 [M+H]+, 
243.53 [Trt]+. 
 
N4-Nosyl-N8-phthaloyl-N1-tritylspermidine (1b). Quantities of reagents: 16 (0.90 g, 
1.80 mmol), 11 (0.51 g, 2.34 mmol), TPP (1.20 g, 4.50 mmol), DIAD (0.89 mL, 
4.50 mmol); Reaction temperature and time: 25 oC, overnight then 40 oC, 2 h; 
Slightly yellow oil (1.04 g, 82%); Rf (N): 0.20; 1H NMR (600 MHz, CDCl3) δ 8.00-
7.97 (m, 1H), 7.83-7.79 (m, 2H), 7.73-7.69 (m, 2H), 7.65-7.60 (m, 2H), 7.56-7.54 
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(m, 1H), 7.46-7.40 (m, 6H), 7.30-7.25 (m, 6H), 7.21-7.16 (m, 3H), 3.68 (t, J = 6.6 
Hz, 2H), 3.40 (t, J = 7.8 Hz, 2H), 3.33 (t, J = 7.8 Hz, 2H), 2.11 (t, J = 6.6 Hz, 2H), 
1.74-1.65 (m, 4H), 1.60-1.55 (m, 3H) ppm; 13C{1H} NMR (150 MHz, CDCl3) δ 
168.3 (2C), 148.0, 145.9 (3C), 134.0 (2C), 133.6, 133.3, 132.1 (2C), 131.5, 130.8, 
128.6 (6C), 127.8 (6C), 126.3 (3C), 124.1, 123.3 (2C), 70.9, 46.8, 45.8, 40.9, 37.2, 
29.6, 25.7, 25.5 ppm; HRMS (Orbitrap-ESI) m/z calcd for C40H39N4O6S [M+ H]+ 
703.2590, found 703.2612.  
 
N1-Dde-N4-nosyl-N7-tritylnorspermidine (2). Quantities of reagents: 16 (1.30 g, 2.60 
mmol), 10a (0.81 g, 3.38 mmol), TPP (1.13 g, 4.18 mmol), DIAD (0.82 mL, 4.18 
mmol); Reaction time: overnight; Reaction temperature: 25 oC; Yellow oil (1.67 g, 
89%); Rf (Q): 0.25; 1H NMR (600 MHz, CDCl3) δ 13.50 (unresolv. t, 1H), 8.01 (dd, 
J = 7.2 and 0.6 Hz, 1H), 7.67 (td, J = 7.2 and 0.6 Hz, 1H), 7.63 (td, J = 7.8 and 0.6 
Hz, 1H), 7.59 (dd, J = 7.8 and 0.6 Hz, 1H), 7.46-7.37 (m, 6H), 7.29-7.23 (m, 6H), 
7.20-7.14 (m, 3H), 3.44-3.37 (m, 6H), 3.52 (s, 3H), 3.31 (s, 4H), 2.11 (t, J = 6.6 Hz, 
2H), 1.93 (quint., J = 7.2 Hz, 2H), 1.72 (quint., J = 6.6 Hz, 2H), 1.64 (br. s, 1H), 
1.00 (s, 6H) ppm; 13C{1H} NMR (150 MHz, CDCl3) δ 199.1 (2C), 173.8, 148.0, 
145.9 (3C), 133.6, 133.0, 131.7, 131.0, 128.6 (6C), 127.8 (6C), 126.3 (3C), 124.2, 
108.0, 70.9, 53.6, 52.2, 46.1, 44.8, 40.9, 40.6, 30.1, 29.4, 28.2 (2C), 28.0, 17.9 ppm; 
HRMS (Orbitrap-ESI) m/z calcd for C41H47N4O6S [M+H]+ 723.3216, found 
723.3201. 
 
N5-Nosyl-N1-phthaloyl-N9-tritylhomospermidine (3). Quantities of reagents: 14 (263 
mg, 0.51 mmol), 11 (145 mg, 0.66 mmol), TPP (345 mg, 1.28 mmol), DIAD (0.25 
mL, 1.28 mmol); Reaction temperature and time: 25 oC, overnight then 40 oC, 2 h; 
Slightly yellow oil (0.29 g, 80%); Rf (N): 0.20; 1H NMR (600 MHz, CDCl3) δ 7.99-
7.95 (m, 1H), 7.83-7.80 (m, 2H), 7.72-7.67 (m, 2H), 7.60-7.57 (m, 2H), 7.56-7.52 
(m, 1H), 7.46-7.41 (m, 6H), 7.29-7.23 (m, 6H), 7.20-7.14 (m, 3H), 3.64 (t, J = 7.2 
Hz, 2H), 3.31 (t, J = 7.2 Hz, 2H), 3.26 (t, J = 7.2 Hz, 2H), 2.71 (t, J = 6.6 Hz, 2H), 
1.64 (quint., J = 7.2 Hz, 2H), 1.59-1.51 (m, 5H), 1.42 (quint., J = 6.6 Hz, 2H) ppm; 
13C{1H} NMR (150 MHz, CDCl3) δ 168.3 (2C), 148.0, 146.2 (3C), 134.0 (2C), 
133.8, 133.3, 132.1 (2C), 131.5, 130.8, 128.6 (6C), 127.8 (6C), 126.2 (3C), 124.1, 
123.3 (2C), 70.8, 42.5, 46.7, 43.1, 37.2, 27.9, 26.1, 25.7, 25.4 ppm; HRMS (Or-
bitrap-ESI) m/z calcd for C41H41N4O6S [M+ H]+ 717.2747, found 717.2722. 
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N1-Dde-N4,N8-dinosyl-N12-tritylspermine (4). Quantities of reagents: 18 (811 mg, 
1.07 mmol), 10a (333 mg, 1.39 mmol), TPP (468 mg, 1.74 mmol), DIAD (0.34 mL, 
1.74 mmol); Reaction time: overnight; Reaction temperature: 25 oC; Yellow oil; Rf 
(R): 0.17; MS (ESI, 30 eV): m/z 1001.60 [M+Na]+, 979.01 [M+H]+, 243.57 [Trt]+. 
The NMR and HRMS spectra of compound 4 are provided below. 
 
N1-Dde- N4,N8-dinosyl-N11-tritylnorspermine (5). Quantities of reagents: 17 (185 
mg, 0.25 mmol), 10a (77 mg, 0.32 mmol), TPP (172 mg, 0.64 mmol), DIAD (0.13 
mL, 0.64 mmol); Reaction time: overnight; Reaction temperature: 25 oC; Yellow 
oil; Rf (Q): 0.15; MS (ESI, 30 eV): m/z 1003.51 [M+K]+, 965.22 [M+H]+. 
The NMR and HRMS spectra of compound 5 are provided below. 
 
N5,N10-Dinosyl-N1-phthaloyl-N14-tritylhomospermine (6). Quantities of reagents: 15 
(295 mg, 0.38 mmol), 11 (107 mg, 0.49 mmol), TPP (226 mg, 0.84 mmol), DIAD 
(0.16 mL, 0.84 mmol). Compound 6 contained DIADH2 in the ratio 1:0.25 (by 1H-
NMR); Reaction temperature and time: 25 oC, 2 h then 40 oC, 1.5 h and finally 25 
oC, overnight; Yellow oil (0.32 g, 87%); Rf (O): 0.28; 1H NMR (600 MHz, CDCl3) 
δ 7.99-7.94 (m, 2H), 7.85-7.81 (m, 2H), 7.72-7.69 (m, 2H), 7.68-7.58 (m, 5H), 7.54-
7.51 (m, 1H), 7.46-7.41 (m, 6H), 7.29-7.23 (m, 6H), 7.20-7.14 (m, 3H), 3.64 (t, J = 
6.6 Hz, 2H), 3.30-3.25 (m, 6H), 3.23 (t, J = 7.2 Hz, 2H), 2.08 (t, J = 6.6 Hz, 2H), 
1.62 (quint., J = 7.2 Hz, 2H), 1.58-1.45 (m, 9H), 1.41 (quint., J = 6.6 Hz, 2H) ppm; 
13C{1H} NMR (150 MHz, CDCl3) δ 168.3 (2C), 148.0 (2C), 146.1 (3C), 134.0 (2C), 
133.7, 133.5, 133.4, 133.3, 132.1 (2C), 131.7, 131.6, 130.7, 130.6, 128.6 (6C), 
127.8 (6C), 126.3 (3C), 124.14, 124.10, 123.2 (2C), 70.8, 47.2, 46.8, 46.7, 46.5, 
43.2, 37.2, 27.9, 26.0, 25.7, 25.4, 25.1, 25.0 ppm; MS (ESI, 30 eV): m/z 995.68 
[M+Na]+, 973.80 [M+H]+, 243.74 [Trt]+. 
 
N1-Dde- N4,N8-dinosyl-N12-tritylthermospermine (7). Quantities of reagents: 13 
(0.76 g, 1 mmol), 10a (0.31 mg, 1.30 mmol), TPP (0.47 mg, 1.75 mmol), DIAD 
(0.34 mL, 1.75 mmol); Reaction time: overnight; Reaction temperature: 25 oC; Yel-
low oil (0.82 g, 84%); Rf (EtOAc): 0.38; 1H NMR (600 MHz, CDCl3) δ 13.47 (un-
resolv. t, 1H), 8.05-8.01 (m, 1H), 7.96 (dd, J = 7.2 and 1.2 Hz, 1H), 7.69-7.61 (m, 
   23 
4H), 7.59 (dd, J = 7.8 and 1.2 Hz, 1H), 7.58-7.55 (m, 1H), 7.45-7.41 (m, 6H), 7.29-
7.24 (m, 6H), 7.20-7.15 (m, 3H), 3.40 (t, J = 7.2 Hz, 2H), 3.37 (q, J = 7.2 Hz, 2H), 
3.30 (t, J = 7.2 Hz, 2H), 3.27 and 3.24 (two t, J = 7.2 Hz, 4H), 2.48 (s, 3H), 2.35 (br. 
s, 4H), 2.06 (t, J = 7.2 Hz, 2H), 1.91 and 1.86 (two quint., J = 7.2 Hz, 4H), 1.61 (br. 
s, 1H), 1.53 (quint., J = 7.2 Hz, 1H), 1.40 (quint., J = 7.2 Hz, 2H), 1.02 (s, 6H) ppm; 
13C{1H} NMR (150 MHz, CDCl3) δ 173.8, 148.0, 147.9, 146.1 (3C), 133.8, 133.6, 
133.2, 132.7, 132.0, 131.7, 131.2, 130.8, 128.6 (6C), 127.8 (6C), 126.3 (3C), 124.2, 
124.1, 108.1, 70.8, 47.8, 45.2, 45.1, 44.9, 43.1, 40.4, 30.0, 28.3 (2C), 27.9, 27.8, 
27.5, 26.0, 17.9 ppm; HRMS (Orbitrap-ESI) m/z calcd for C51H59N6O10S2 [M+H]+ 
979.3734, found 979.3718. 
 
N1-Dde-N4,N8,N13-trinosyl-N16-trityl-4,8,13-triazahexadecane-1,16-diamine (26a). 
Quantities of reagents: 23 (101 mg, 0.10 mmol), 10a (31 mg, 0.13 mmol), TPP (105 
mg, 0.40 mmol), DIAD (0.08 mL, 0.40 mmol); Reaction temperature and time: 25 
oC, overnight then 40 oC, 2 h; Yellow oil; Rf (R): 0.18. 
The NMR and HRMS spectra of compound 26a are provided below. 
 
Preparation of 2-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)acetic acid (20b) 
A. Protection of the carboxyl function of IAA with the phenacyl group  
To an ice-cold solution of IAA (0.175 g, 1 mmol) and dry Et3N (0.20 mL, 1.34 
mmol) in dry DMF (3 mL), 2-bromoacetophenone (0.23 g, 1.16 mmol) was added 
under an inert atmosphere and the reaction was stirred at 0 oC for 30 min. The reac-
tion mixture was then allowed to reach room temperature and further stirred for 2 h. 
The completion of the reaction was confirmed by TLC using the solvent system C. 
The reaction mixture was diluted with H2O and extracted thrice with EtOAc. The 
organic layer washed twice with H2O and once with brine and then was dried over 
Na2SO4 and evaporated to dryness. The desired product, that is phenacyl 2-(1H-
indol-3-yl)acetate, was obtained pure following FCC and using solvent system V as 
eluant. 
White solid (0.24 g, 81%); mp 87.8-90.0 oC;  Rf (W): 0.44; 1H NMR (600 MHz, 
CDCl3) δ 8.14 (br. s, 1H), 7.89 (dd, J = 8.1 and 1.3 Hz, 2H), 7.66 (d, J = 8.4 Hz, 
1H), 7.59 (tt, J = 8.1 and 1.3 Hz, 1H), 7.46 (t, J = 8.1 Hz, 2H), 7.36 (d, J = 7.8 Hz, 
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1H), 7.26 (br. s, 1H), 7.22-7.19 (m, 1H), 7.16-7.14 (m, 1H),  5.36 (s, 2H), 3.98 (un-
resolv. d, 2H) ppm; 13C{1H} NMR (150 MHz, CDCl3) δ 192.7, 171.9, 136.5, 134.7, 
134.3, 129.2 (2C), 128.2 (2C), 127.7, 123.7, 122.6, 120.1, 119.3, 111.6, 108.4, 66.7, 
31.3 ppm; MS (ESI, 30 eV): m/z 332.34 [M+Κ]+, 316.40 [M+Na]+. 
 
B. Protection of the amino function of phenacyl 2-(1H-indol-3-yl)acetate with the 
Boc-group 
To an ice-cold solution of phenacyl 2-(1H-indol-3-yl)acetate (0.24 g, 0.81 mmol), 
dry Et3N (0.12 mL, 0.89 mmol) and DMAP (10 mg, 0.08 mmol) in dry CH2Cl2 (2 
mL), Boc2O (0.19 g, 0.89 mmol) was added under an inert atmosphere. The reaction 
was kept for 3 h at room temperature. The completion of the reaction was confirmed 
by TLC using the solvent system V. Then, the reaction mixture was diluted with 
CH2Cl2 and washed twice with H2O and once with brine. The organic layer was 
dried over Na2SO4 and evaporated to dryness. The desired product, that is phenacyl 
2-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)acetate, was obtained pure following puri-
fication by FCC and using the solvent system U as eluant.  
Yellow oil (0.29 g, 91%); Rf (U): 0.20; 1H NMR (600 MHz, CDCl3) δ 8.15 (br. s, 
1H), 7.89 (dd, J = 8.4 and 1.2 Hz, 2H), 7.67 (br. s, 1H), 7.61-7.58 (m, 2H), 7.49-
7.46 (m, 2H), 7.35-7.32 (m, 1H), 7.28-7.25 (m, 1H), 5.38 (s, 2H), 3.92 (unresolv. d, 
2H), 1.67 (s, 9H) ppm; 13C{1H} NMR (150 MHz, CDCl3) δ 192.4, 170.9, 150.0, 
135.9, 134.6, 134.3, 130.5, 129.3 (2C), 128.2 (2C), 125.1, 125.0, 123.1, 119.5, 
115.7, 113.1, 84.0, 66.9, 31.1, 28.6 (3C) ppm; MS (ESI, 30 eV): m/z 809.13 
[2M+Na]+, 416.15 [M+Na]+. 
 
C. Deprotection of the carboxyl function of phenacyl 2-(1-(tert-butoxycarbonyl)-
1H-indol-3-yl)acetate 
To a solution of phenacyl 2-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)acetate (0.29 g, 
0.74 mmol) in DMF (7 mL), Na2CO3 (0.41 g, 3.91 mmol) first and then PhSH (0.30 
mL, 2.96 mmol) were added under an inert atmosphere. The reaction mixture was 
kept at 60 ºC for 2 h. The completion of the reaction was confirmed by TLC using 
the solvent system U. The reaction mixture was then diluted with 5% citric acid and 
extracted with EtOAc. The organic layer washed twice with H2O and once with 
brine, dried over Na2SO4 and evaporated to dryness. The product Nind-Boc-IAA 
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(20b) was obtained pure following FCC purification and using solvent system R as 
eluant.  
White solid (0.17 g, 84%); mp 117-120 oC; Rf (R): 0.17; 1H NMR (600 MHz, 
CDCl3) δ 8.14 (br. s, 1H), 7.58 (br. s, 1H), 7.53 (d, J = 7.8 Hz, 1H), 7.33 (t, J = 7.8 
Hz, 1H), 7.25 (t, J = 7.8 Hz, 1H), 3.75 (s, 2H), 1.66 (s, 9H) ppm; 13C{1H} NMR 
(150 MHz, CDCl3) δ 176.9, 150.0, 135.8, 130.3, 129,4, 125.0, 123.1, 119.4, 115.7, 
112.9, 84.2, 31.2, 28.6 (3C) ppm.   
 
General procedure for coupling IAA (20a) or N-Boc-IAA (20b) with 4-
aminobutan-1-ol 
To an ice-cold solution of IAA or N-Boc-IAA (1 mmol) and HOSu (0.23 g, 2 
mmol) in DMF (4 mL), DCC (0.23 g, 1.1 mmol) was added under an inert atmos-
phere. After 15 min at 0 ºC, the reaction mixture was further stirred at room temper-
ature for 2 h. Completion of the activation reaction was confirmed by TLC using 
solvent system C. Then, 4-aminobutan-1-ol (0.3 mL, 3 mmol) was added and the 
reaction was completed within a few minutes. A few drops of H2O and one drop of 
gl. acetic acid were added to the reaction mixture in order to destroy excess of DCC. 
The reaction mixture was then diluted with EtOAc and the precipitated urea was 
removed by filtration. The filtrate was diluted with EtOAc and washed twice with 
5% NaHCO3 and twice with H2O, dried over Na2SO4 and evaporated to dryness. 
The product was obtained pure following FCC purification and using solvent sys-
tem C as eluant.  
 
 
N-(4-Hydroxybutyl)-2-(1H-indol-3-yl)acetamide (21a). Orange solid (0.16 g, 65%); 
mp 80.0-83.6 oC; Rf (C): 0.23; 1H NMR (600 MHz, CDCl3) δ 8.55 (br. s, 1H), 7.55 
(d, J = 7.8 Hz, 1H), 7.40 (d, J = 8.4 Hz, 1H), 7.23 (td, J = 8.4 and 0.6 Hz, 1H), 7.15 
(ddd, J = 8.4, 7.8 and 0.6 Hz, 1H), 7.12 (d, J = 2.4 Hz, 1H), 5.89 (unresolv. t, 1H), 
3.73 (s, 2H), 3.52 (t, J = 6 Hz, 2H), 3.20 (q, J = 6.6 Hz, 2H), 1.48-1.40 (m, 5H) 
ppm; 13C{1H} NMR (150 MHz, CDCl3) δ 171.8, 136.5, 127.1, 123.9, 122.6, 120.0, 
118.7, 111.5, 109.0, 62.3, 39.3, 33.4, 29.6, 26.0 ppm; Anal. Calcd (%) for 
C14H18N2O2: C, 68.27; H, 7.37; N, 11.37. Found: C, 68.48; H, 7.52; N, 11.48.  
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tert-Butyl 3-(2-((4-hydroxybutyl)amino)-2-oxoethyl)-1H-indole-1-carboxylate (21b). 
Beige solid (0.13 g, 72%); mp 122-126 oC; Rf (C): 0.43; 1H NMR (600 MHz, 
CDCl3) δ 8.15 (d, J = 6.6 Hz, 1H), 7.54 (s, 1H), 7.51 (d, J = 7.8 Hz, 1H), 7.35 (td, J 
= 6.6 and 0.6 Hz, 1H), 7.26 (ddd, J = 7.8, 6.6 and 0.6 Hz, 1H), 5.78 (unresolv. t, 
1H), 3.66 (s, 2H), 3.56 (t, J = 6 Hz, 2H), 3.23 (q, J = 6 Hz, 2H), 1.68 (s, 9H), 1.51-
1.45 (m, 5H) ppm; 13C{1H} NMR (150 MHz, CDCl3) δ 170.3 (2C), 149.5, 129.8, 
125.0, 124.9, 122.9, 119.0, 115.4, 113.9, 84.1, 62.3, 39.4, 33.3, 29.6, 28.2 (3C), 26.1 
ppm; Anal. Calcd (%) for C19H26N2O4: C, 65.87; H, 7.56; N, 8.09. Found: C, 66.12; 
H, 7.38; N, 7.95.  
 
Coupling of Nsm derivative 22 with alcohol 21b under Mitsunobu reac-
tion conditions - Synthesis of the crude fully protected toxin HO-416b 
(23a). Quantities of reagents: 22 (197 mg, 0.20 mmol), 21b (90 mg, 0.26 mmol), 
TPP (140 mg, 0.52 mg), DIAD (0.1 mL, 0.52 mmol), dry THF (0.6 mL); Reaction 
time: overnight; Reaction temperature: 40 oC; Slightly yellow oil; Rf (S): 0.29; 1H 
NMR (600 MHz, CDCl3) δ 8.16 (unresolv. d, 1H), 8.00 (dd, J = 7.8 and 0.6 Hz, 
1H), 7.97-7.93 (m, 2H), 7.72-7.63 (m, 4H), 7.60-7.54 (m, 5H), 7.53-7.48 (m, 2H), 
7.44-7.40 (m, 6H), 7.33 (t, J = 7.8 Hz, 1H), 7.30-7.23 (m, 7H), 7.21-7.15 (m, 3H), 
5.80 (t, J = 6.6 Hz, 1H), 3.64 (s, 2H), 3.37 (t, J = 7.2 Hz, 2H), 3.39-3.24 and 3.24-
3.20 (two m, 10H), 3.18 (q, J = 6.6 Hz, 2H), 2.09 (t, J = 6.6 Hz, 2H), 1.86-1.77 (m, 
4H), 1.68 (s, 9H), 1.61 (br. s, 1H), 1.51-1.45 (m, 4H), 1.39 (quint., J = 7.2 Hz, 2H) 
ppm; MS (ESI, 30 eV): m/z 1314.32 [M+H]+, 243.18 [Trt]+. 
 
General procedure for the alkylation of N-nosylated PAs with bromide 
10c 
A typical procedure for the alkylation of N-nosylated PAs with bromide 10c is the 
following: 
To a solution of  dinosylated derivative 17 (1.31 g, 1.76 mmol) and bromide 10c 
(0.59 g, 1.94 mmol) in dry DMF (3 mL), K2CO3 (0.53 g, 3.70 mmol) was added un-
der an inert atmosphere. The reaction mixture was stirred at 60 oC for 2.5 h. The 
progress of the reaction was monitored by TLC using the solvent system R. The re-
action mixture was then diluted with H2O and extracted once with EtOAc. The or-
ganic layer was washed twice with H2O and once with brine. It was then dried over 
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Na2SO4 and it was evaporated to dryness. The product 5 was obtained pure follow-
ing FCC purification using solvent system Q as eluant.  
The same procedure was used for the synthesis of  Spm derivative 4 and the penta-
amine derivative 26a.  
 
N1-Dde- N4,N8-dinosyl-N12-tritylspermine (4). Yellow oil (0.43 g, 88%); Rf (R): 
0.17; 1H-NMR (600 MHz, CDCl3) δ 13.48 (unresolv. t, 1H), 8.04 (dd, J = 7.8 and 
1.2 Hz, 1H), 7.99 (dd, J = 7.8 and 1.2 Hz, 1H), 7.71-7.63 (m, 4H), 7.62-7.58 (m, 
2H), 7.45-7.39 (m, 6H), 7.31-7.25 (m, 6H), 7.22-7.16 (m, 3H), 3.44-3.38 (m, 4H), 
3.37-3.33 (m, 4H), 3.31 (t, J = 6.6 Hz, 2H), 2.51 (s, 3H), 2.37 (s, 4H), 2.09 (t, J = 
6.6 Hz, 2H), 1.94 (quint., J = 6.6 Hz, 2H), 1.67 (quint., J = 6.6 Hz, 2H), 1.62-1.51 
(m, 5H), 1.04 (s, 6H) ppm; 13C{1H} NMR (150 MHz, CDCl3) δ 173.7, 147.99, 
147.96, 145.9 (3C), 133.7, 133.5, 133.4, 133.0, 131.9, 131.6, 131.0, 130.8, 128.6 
(6C), 127.8 (6C), 126.3 (3C), 124.2 (2C), 108.0, 70.9, 53.5, 52.3, 47.0, 46.6, 45.6, 
44.7, 40.9, 40.5, 30.1, 29.4, 28.3 (2C), 27.9, 25.0, 24.8, 17.8 ppm; HRMS (Orbitrap-
ESI) m/z calcd for C51H59N6O10S2 [M+H]+ 979.3734, found 979.3729.  
 
N1-Dde- N4,N8-dinosyl-N11-tritylnorspermine (5). Yellow oil; (1.29 g, 76%); Rf (Q): 
0.15; 1H NMR (600 MHz, CDCl3) δ 13.49 (unresolv. t, 1H), 8.07-8.03 (m, 1H), 7.98 
(dd, J = 7.8 and 0.6 Hz, 1H), 7.70-7.63 (m, 4H), 7.59 (dd, J = 7.8 and 1.2 Hz, 1H), 
7.58-7.55 (m, 1H), 7.43-7.38 (m, 6H), 7.29-7.23 (m, 6H), 7.20-7.14 (m, 3H), 3.44-
3.39 (m, 4H), 3.39-3.35 (m, 2H), 3.31 (t, J = 7.2 Hz, 2H), 3.27 (t, J = 7.2 Hz, 2H), 
2.50 (s, 3H), 2.36 (s, 4H), 2.08 (t, J = 6.6 Hz, 2H), 1.93 (quint., J = 7.2 Hz, 2H), 
1.86 (quint., J  = 7.2 Hz, 2H), 1.66 (quint., J = 6.6 Hz, 2H), 1.57 (br. s, 1H), 1.03 (s, 
6H) ppm; 13C{1H} NMR (150 MHz, CDCl3) δ 173.8, 148.0, 147.9, 145.7 (3C), 
133.8, 133.6, 133.0, 132.7, 132.0, 131.7, 131.2, 130.8, 128.6 (6C), 127.9 (6C), 
126.3 (3C), 124.22, 124.21, 108.1, 70.9, 46.0, 45.3, 45.1, 44.9, 40.9, 40.5, 30.1, 
29.4, 28.3 (2C), 27.9, 27.5, 17.9 ppm; HRMS (Orbitrap-ESI) m/z calcd for 
C50H57N6O10S2 [M+H]+ 965.3578, found 965.3541. 
 
 
N1-Dde-N4,N8,N13-trinosyl-N16-trityl-4,8,13-triazahexadecane-1,16-diamine (26a). 
Reaction time: 2.5 h; Reaction temperature: 60 oC; Yellow oil (0.85 g, 72%); Rf (R): 
0.18; 1H NMR (600 MHz, CDCl3) δ 13.45 (unresolv. t, 1H), 8.05-8.02 (m, 1H), 
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7.99-7.95 (m, 2H), 7.71-7.65 (m, 5H), 7.64 (td, J = 7.2 and 1.2 Hz, 1H), 7.61-7.56 
(m, 3H), 7.42-7.38 (m, 6H), 7.28-7.23 (m, 6H), 7.20-7.14 (m, 3H), 3.41 (t, J = 7.2 
Hz, 2H), 3.38 (q, J = 6.6 Hz, 2H), 3.33 (t, J = 7.8 Hz, 2H), 3.21-3.27 (m, 6H), 3.24 
(t, J = 7.2 Hz, 2H), 2.48 (s, 3H), 2.36 (s, 4H), 2.06 (t, J = 6.6 Hz, 2H), 1.91 (quint., J 
= 7.8 Hz, 2H), 1.86 (quint., J = 6.6 Hz, 2H), 1.64 (quint., J = 7.2 Hz, 2H), 1.54-1.50 
(m, 5H), 1.03 (s, 6H) ppm; 13C{1H} NMR (150 MHz, CDCl3) δ 173.8, 148.0 (2C), 
147.9, 145.9 (3C), 133.9, 133.7, 133.5, 133.3, 133.0, 132.7, 132.0, 131.9, 131.7, 
131.1, 130.8, 130.7, 128.6 (6C), 127.8 (6C), 126.3 (3C), 124.24, 124.20 (2C), 108.0, 
70.9, 47.2, 46.6, 45.6, 45.1, 45.0 (2C), 40.9, 40.5, 30.1, 29.4, 28.3 (2C), 27.8, 27.3, 
25.0, 24.9, 17.9 ppm; HRMS (Orbitrap-ESI) m/z calcd for C60H69N8O14S3 [M+H]+ 
1221.4095, found 1221.4077. 
 
General procedure for the selective removal of the Dde group 
A typical procedure for the selective removal of the Dde group from fully protected 
PAs and conjugates is the following: 
To a solution of N1-Dde-N4-nosyl-N8-tritylspermidine (1a) (0.85 g, 1.16 mmol) in 
DMF (15 mL), H2NNH2∙H2O (0.30 mL, 6.15 mmol) was added. The reaction mix-
ture was stirred at room temperature for 30 min. The progress of the reaction was 
monitored by TLC using EtOAc as eluant. The reaction mixture was then diluted 
with CH2Cl2 and washed twice with H2O and once with brine. The organic layer 
was dried over Na2SO4 and evaporated to dryness. The product was obtained pure 
following FCC purification using initially solvent system E, to remove non-polar 
fractions, and then solvent system H as eluants.  
The same procedure was used for the preparation of the partially protected PAs tab-
ulated below. The solvent systems used for the purification of the following com-
pounds are also provided. 
 
N4-Nosyl-N8-tritylspermidine. Slightly yellow oil (0.58 g, 87%); Rf (E): 0.10; Sol-
vent systems used for FCC purification: initially E, then H; 1H NMR (600 MHz, 
CDCl3) δ 7.98 (dd, J = 7.8 and 1.8 Hz, 1H), 7.66-7.60 (m, 2H), 7.59 (dd, J = 7.8 and 
1.8 Hz, 1H), 7.45-7.42 (m, 6H), 7.28-7.24 (m, 6H), 7.20-7.16 (m, 3H), 3.37 (t, J = 
7.2 Hz, 2H), 3.27 (t, J = 7.2 Hz, 2H), 2.72 (t, J = 6.6 Hz, 2H), 2.08 (t, J = 6.6 Hz, 
2H), 1.68 (quint., J = 6.6 Hz, 2H), 1.59-1.54 (m, 5H), 1.42 (quint., J = 7.2 Hz, 2H) 
ppm; 13C{1H} NMR (150 MHz, CDCl3) δ 148.1, 146.1 (3C), 133.7, 133.3, 131.6, 
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130.7, 128.6 (6C), 127.8 (6C), 126.2 (3C), 124.1, 70.8, 47.5, 45.0, 43.1, 40.0, 31.6, 
27.9, 26.0 ppm; HRMS (Orbitrap-ESI) m/z calcd for C32H37N4O4S [M+H]+ 
573.2536, found 573.2522. 
 
N4-Nosyl-N1-tritylnorspermidine. Yellow oil (1.05 g, 72%); Rf (E): 0.15; Solvent 
systems used for FCC purification: initially E, then H; 1H NMR (600 MHz, CDCl3) 
δ 7.99 (unresolv. dd, 1H), 7.67-7.60 (m, 2H), 7.58 (d, J = 7.8 Hz, 1H), 7.43-7.39 (m, 
6H), 7.28-7.24 (m, 6H), 7.20-7.16 (m, 3H), 3.39 and 3.36 (two t, J = 7.2 Hz, 4H), 
2.71 (t, J = 6.6 Hz, 2H), 2.09 (t, J = 6.6 Hz, 2H), 1.73-1.64 (m, 4H), 1.51 (br. s, 3H) 
ppm; 13C{1H} NMR (150 MHz, CDCl3) δ 148.1, 145.9 (3C), 133.5, 133.3, 131.5, 
130.8, 128.6 (6C), 127.8 (6C), 126.3 (3C), 124.2, 70.9, 45.7, 45.1, 40.9, 39.0, 31.7, 
24.5 ppm; HRMS (Orbitrap-ESI) m/z calcd for C31H35N4O4S [M+H]+ 559.2379, 
found 559.2402. 
 
N4,N9-Dinosyl-N1-tritylspermine. Yellow oil (0.79 g, 91%); Rf (G): 0.19; Solvent 
systems used for FCC purification: initially G, then H; 1H NMR (600 MHz, CDCl3) 
δ 8.00-7.96 (m, 2H), 7.68-7.62 (m, 4H), 7.59-7.56 (m, 2H), 7.43-7.39 (m, 6H), 7.28-
7.24 (m, 6H), 7.20-7.16 (m, 3H), 3.36-3.32 and 3.32-3.26 (two m, 8H), 2.69 (t, J = 
6.6 Hz, 2H), 2.07 (t, J = 6.6 Hz, 2H), 1.70-1.63 (m, 4H), 1.53 (unresolv. m, 7H) 
ppm; 13C{1H} NMR (150 MHz, CDCl3) δ 148.44, 148.39, 146.3 (3C), 133.9, 133.8, 
132.1, 132.0, 131.12, 131.08, 129.0 (6C), 128.2 (6C), 126.7 (3C), 124.6, 124.5, 
71.3, 47.3, 47.1, 46.0, 45.5, 41.3, 39.4, 32.1, 29.8, 25.5, 25.4 ppm; HRMS (Or-
bitrap-ESI) m/z calcd for C41H47N6O8S2 [M+H]+ 815.2897, found 815.2868. 
 
N4,N8-Dinosyl-N1-tritylnorspermine. Yellow oil (1.51 g, 94%); Rf (G): 0.18; Solvent 
systems used for FCC purification: initially G then J; 1H NMR (600 MHz, CDCl3) δ 
8.02-7.97 (m, 2H), 7.69-7.63 (m, 4H), 7.60-7.57 and 7.57-7.54 (two m, 2H), 7.44-
7.38 (m, 6H), 7.29-7.24 (m, 6H), 7.21-7.16 (m, 3H), 3.37 (t, J = 7.2 Hz, 4H), 3.29 
and 3.27 (two t, J = 7.2 Hz, 4H), 2.70 (t, J = 6.6 Hz, 2H), 2.08 (t, J = 6.6 Hz, 2H), 
1.86 (quint., J = 7.2 Hz, 2H), 1.70-1.63 (m, 4H), 1.44 (br. s, 3H) ppm; 13C{1H} 
NMR (150 MHz, CDCl3) δ 148.44, 148.40, 146.3 (3C), 134.0, 133.9, 133.53, 
133.47, 132.16, 132.09, 131.23, 131.22, 129.0 (6C), 128.2 (6C), 126.7 (3C), 124.6, 
124.6, 71.3, 46.4, 45.9, 45.5, 45.4, 41.3, 39.3, 32.1, 29.8, 27.9 ppm; HRMS (Or-
bitrap-ESI) m/z calcd for C40H45N6O8S2 [M+H]+ 801.2740, found 801.2752. 
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N4,N8,N13-Trinosyl-N16-trityl-4,8,13-triazahexadecane-1,16-diamine (26b). Orange 
oil; (0.85 g, 83%); Rf (G): 0.11; Solvent systems used for FCC purification: initially 
G, then H; 1H NMR (600 MHz, CDCl3) δ 8.00-7.96 (m, 3H), 7.69-7.63 (m, 6H), 
7.59-7.56 (m, 3H), 7.42-7.38 (m, 6H), 7.27-7.23 (m, 6H), 7.19-7.15 (m, 3H), 3.37-
3.32 (m, 4H), 3.28-3.27 (m, 6H), 3.23 (t, J = 7.2 Hz, 2H), 2.67 (t, J = 6.6 Hz, 2H), 
2.06 (t, J = 6.6 Hz, 2H), 1.83 (quint., J = 7.2 Hz, 2H), 1.65 (quint., J = 7.2 Hz, 4H), 
1.54-1.45 (m, 7H) ppm; 13C{1H} NMR (150 MHz, CDCl3) δ 148.03, 147.98, 
147.96, 145.9 (3C), 133.63, 133.62, 133.5, 133.4, 133.04, 133.03, 131.9, 131.8, 
131.7, 130.83, 130.75, 130.70, 128.6 (6C), 127.8 (6C), 126.3 (3C), 124.18 (2C), 
124.17, 70.9, 47.1, 46.7, 45.6, 45.5, 44.96, 44.94, 40.9, 38.9, 31.7, 29.4, 27.4, 25.0, 
24.9 ppm; HRMS (Orbitrap-ESI) m/z calcd for C50H57N8O12S3 [M+H]+ 1057.3258, 
found 1057.3237. 
 
General procedure for the selective removal of the Phth group 
A typical procedure for the selective removal of the Phth group from fully protected 
PAs is the following: 
To a solution of fully protected Spd 1b (1.26 g, 1.80 mmol) in EtOH (12 mL) 
H2NNH2∙H2O (0.18 mL, 3.60 mmol) was added. The reaction mixture was then 
heated under reflux for 1 h. The progress of the reaction was monitored by TLC us-
ing the solvent system N. Then, additional H2NNH2∙H2O (0.18 mL, 3.6 mmol) was 
added and the reaction mixture was further refluxed for an additional 1 h. Following 
completion of the reaction, the resulting mixture was allowed to attain room tem-
perature and the solvent was evaporated. The residue was diluted with 10% Na-
HCO3 and extracted with CH2Cl2. The organic layer washed once with brine and 
then was dried over Na2SO4. Filtration and evaporation of the filtrate to dryness 
provided a residue from which the desired product was obtained pure through FCC 
purification using the solvent systems indicated below. 
The same procedure was used for the removal of the Phth group from the fully pro-
tected Hsp derivative 3. 
 
N4-Nosyl-N1-tritylspermidine. Slightly yellow oil (0.97 g, 94%); Rf (H): 0.34; Sol-
vent system for FCC purification: initially G, then H; 1H NMR (600 MHz, CDCl3) δ 
7.99 (dd, J = 7.8 and 1.8 Hz, 1H), 7.67-7.60 (m, 2H), 7.58 (dd, J = 7.8 and 1.2 Hz, 
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1H), 7.44-7.39 (m, 6H), 7.30-7.24 (m, 6H), 7.20-7.16 (m, 3H), 3.38 (t, J = 7.2 Hz, 
2H), 3.28 (t, J = 7.2 Hz, 2H), 2.68 (t, J = 7.2 Hz, 2H), 2.10 (t, J = 6.6 Hz, 2H), 1.69 
(quint., J = 7.2 Hz, 2H), 1.57 (quint., J = 7.2 Hz, 2H), 1.48-1.41 (br. s, 3H), 1.41 (m, 
2H) ppm; 13C{1H} NMR (150 MHz, CDCl3) δ 148.0, 145.9 (3C), 133.7, 133.3, 
131.5, 130.8, 128.6 (6C), 127.8 (6C), 126.3 (3C), 124.2, 70.9, 47.3, 45.5, 41.7, 40.9, 
30.6, 29.5, 25.7 ppm; HRMS (Orbitrap-ESI) m/z calcd for C32H37N4O4S [M+H]+ 
573.2536, found 573.2561. 
 
N5-Nosyl-N1-tritylhomospermidine. Υellow oil (0.28 g, 93%); Rf (H): 0.30; Solvent 
systems for FCC purification: initially G, then H; 1H NMR (600 MHz, CDCl3) δ 
7.98 (dd, J = 7.8 and 1.2 Hz, 1H), 7.67-7.60 (m, 2H), 7.59 (dd, J = 7.8 and 0.6 Hz, 
1H), 7.46-7.42 (m, 6H), 7.29-7.24 (m, 6H), 7.20-7.16 (m, 3H), 3.28 (two overlap. t, 
J = 7.8 Hz, 4H), 2.67 (t, J = 7.2 Hz, 2H), 2.08 (t, J = 6.6 Hz, 2H), 1.57 (quint., J = 
7.8 Hz, 4H), 1.46-1.34 (m, 7H) ppm; 13C{1H} NMR (150 MHz, CDCl3) δ 148.4, 
146.5 (3C), 134.2, 133.7, 131.9, 131.2, 129.0 (6C), 128.2 (6C), 126.6 (3C), 124.5, 
71.2, 47.7, 47.6, 43.5, 42.1, 30.1, 28.3, 26.4, 26.1 ppm; HRMS (Orbitrap-ESI) m/z 
calcd for C33H39N4O4S [M+H]+ 587.2692, found 587.2664. 
 
Coupling of partially protected penta-amine 26b with IAA (20a) - Syn-
thesis of toxin Agel 416 derivative 27a 
 
To an ice-cold solution of IAA (20a) (0.15 mg, 0.87 mmol) and HOSu (0.20 g, 1.74 
mmol) in dry DMF (3.5 mL), DIC (0.15 mL, 0.96 mmol) was added under an inert 
atmosphere. The reaction mixture was stirred at 0 oC for 30 min and then at room 
temperature for further 2 h. The completion of the activation reaction was con-
firmed by TLC using solvent system C. Then, the penta-amine derivative 26b (0.84 
g, 0.79 mmol) was added to the reaction mixture. The reaction was completed with-
in 2 h. Completion of the reaction was confirmed by TLC using solvent system H. 
Then, the reaction mixture was diluted with EtOAc and washed twice with 5% Na-
HCO3, twice with H2O and once with brine. The organic layer was dried over 
Na2SO4 and evaporated to dryness. FCC of the oily residue, using EtOAc as eluant, 
provided intermediate 27a,  co-eluted with DCIU, which was used as such into the 
next deprotection step  
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Reaction time: 4.5 h; Slightly yellow oil; Rf (EtOAc): 0.20; 1H NMR (600 MHz, 
CDCl3) δ 8.39 (br. s, 1H), 7.95 (dd, J = 7.8 and 1.2 Hz, 1H), 7.93-7.91 (m, 1H), 
7.70-7.60 (m, 8H), 7.59-7.54 (m, 4H), 7.41-7.37 (m, 6H), 7.35 (d, J = 8.4 Hz, 1H), 
7.28-7.22 (m, 6H), 7.21-7.15 (m, 4H), 7.11-7.07 (m, 1H), 6.11 (t, J = 6 Hz, 1H), 
3.71 (s, 2H), 3.31 (t, J = 7.2 Hz, 2H), 3.24 and 3.22 (two t, J = 7.2 Hz, 4H), 3.18 (q, 
J = 6 Hz, 2H), 3.14 (t, J = 7.2 Hz, 2H), 3.09 and 3.09 (two t, J =  7.2 Hz, 4H), 2.07 
(t, J = 6.6 Hz, 2H), 1.68-1.58 (m, 8H), 1.48-1.44 (m, 3H) ppm; 13C{1H} NMR (150 
MHz, CDCl3) δ 171.9, 147.97, 147.95, 147.93, 145.88 (3C), 136.4, 133.70, 133.66, 
133.5, 133.3, 132.9, 132.6, 132.0, 131.9, 131.7, 130.68, 130.65, 130.4, 128.6 (6C), 
127.8, (6C), 127.2, 126.3 (3C), 124.21, 124.16, 124.15, 122.3, 119.8, 118.6, 111.5, 
109.0, 70.9, 47.1, 46.7, 45.6, 45.4, 44.9, 42.2, 40.9, 35.9, 33.5, 29.4, 28.1, 27.5, 
25.0, 24.9 ppm; MS (ESI, 30 eV): m/z 1214.28 [M+H]+. 
 
General procedure for the removal of the Ns group – Preparation of the pen-
ta-amine derivatives 23b and 27b 
A typical procedure for the selective removal of the Ns group from fully protected 
PAs is the following: 
To a solution of crude 23a (0.2 mmol) and PhSH (0.24 mL, 2.40 mmol) in DMF (2 
mL) Na2CO3 (0.32 g, 3 mmol) was added, under an inert atmosphere, and the result-
ing suspension was stirred vigorously overnight. The completion of the reaction was 
confirmed by TLC using initially solvent system S and then solvent system H. The 
reaction mixture was diluted with H2O and extracted twice with CH2Cl2. The organ-
ic layer was washed once with H2O and once with brine, dried over Na2SO4 and 
evaporated to dryness. The product was obtained pure following FCC purification 
using solvent system I as eluant. 
The same procedure was used for the removal of the Ns groups from the penta-
amine derivative 27a. 
 
Partially protected toxin HO-416b (23b). Slightly yellow oil; Rf (I): 0.15; 1H NMR 
(600 MHz, CDCl3) δ 8.17 (unresolv. d, 1H), 7.55 (s, 1H), 7.52 (d, J = 7.8 Hz, 1H), 
7.49-7.45 (m, 6H), 7.38-7.33 (m, 1H), 7.30-7.24 (m, 7H), 7.20-7.16 (m, 3H), 6.02 
(unresolv. t, 1H), 3.66 (s, 2H), 3.21 (q, J = 6.6 Hz, 2H), 2.70-2.60 (m, 8H), 2.58 (t, J 
= 6.6 Hz, 2H), 2.52 (t, J = 7.2 Hz, 2H), 2.19 (t, J = 7.2 Hz, 2H), 1.69 (s, 9H), 1.67 
(quint., J = 7.2 Hz, 4H), 1.61 (quint., J = 6.6 Hz, 2H), 1.45 (quint., J = 6.6 Hz, 2H), 
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1.39 (quint., J = 7.2 Hz, 2H), 1.27 (br. s, 1H) ppm; 13C{1H} NMR (150 MHz, 
CDCl3) δ 170.0 (2C), 149.5, 146.2 (3C), 129.9, 128.7 (6C), 127.8 (6C), 126.2 (3C), 
124.9, 124.8, 122.9, 119.1, 115.4, 114.0, 84.0, 70.9, 49.4, 48.6, 48.5 (3C), 48.4, 
42.1, 39.5, 33.4, 31.0, 30.4, 30.2, 28.2, 27.3 (3C), 27.3 ppm; HRMS (Orbitrap-ESI) 
m/z calcd for C47H63N6O3 [M+H]+ 759.4962, found 759.4985. 
 
Partially protected toxin Agel 416 (27b). Slightly yellow oil; Rf (L): 0.08; 1H NMR 
(600 MHz, CDCl3) δ 9.51 (br. s, 1H), 7.55 (d, J = 7.8 Hz, 1H), 7.48-7.43 (m, 6H), 
7.37 (d, J = 8.4 Hz, 1H), 7.29-7.23 (m, 6H), 7.21-7.15 (m, 4H), 7.12 (t, J = 7.8 Hz, 
1H), 7.10 (br. s, 1H), 6.70 (unresolv. t, 1H), 3.72 (s, 2H), 3.28 (q, J = 6 Hz, 2H), 
2.71 (t, J = 6.6 Hz, 2H), 2.65 (unresolv. t, 2H), 2.61 (unresolv. t, 2H), 2.50 (t, J = 
6.6 Hz, 2H), 2.44 (t, J = 6 Hz, 2H), 2.32 (t, J = 7.2 Hz, 2H), 2.20 (t, J = 6 Hz, 2H), 
1.68 (quint., J = 6 Hz, 2H), 1.59-1.53 (m, 4H), 1.48 (quint., J = 6 Hz, 2H), 1.39 
(quint., J = 6.6 Hz, 2H), 1.26 (br. s, 1H) ppm; 13C{1H} NMR (150 MHz, CDCl3) δ 
171.6, 146.2 (3C), 136.6, 128.6 (6C), 127.8 (6C), 127.3, 126.2 (3C), 124.0, 122.3, 
119.7, 118.8, 11.5, 109.1, 70.9, 49.8, 49.7, 48.5, 48.3, 48.10, 48.05, 42.1, 38.9, 33.5, 
30.9, 29.7, 28.9, 28.0, 27.8 ppm; HRMS (Orbitrap-ESI) m/z calcd for C42H54N6O 
[M+H]+ 659.4437, found 659.4421. 
 
General procedure for the removal of the Trt and Boc N-protecting groups - 
Synthesis of toxins HO-416b and Agel 416 
The penta-amine derivative 23b (84 mg, 0.11 mmol) was dissolved in an ice-cold 
solution made up of TFA (0.1 ml) and PhSH (0.1 mL) in CH2Cl2 (0.9 mL) under an 
inert atmosphere. It was then allowed to attain room temperature where it was left to 
stand for 1 h. The completion of the reactions was confirmed by TLC using the sol-
vent system L. Volatile components were then removed under vacuo and the residue 
was triturated with Et2O and refrigerated overnight. The precipitated penta-
trifluoroacetate salt of toxin HO-416b was obtained by filtration and drying under 
vacuo overnight.  
Similarly, penta-amine derivative 27b (0.2 g, 0.3 mmol) was dissolved in an ice-
cold solution made up of TFA (0.27 ml) and PhSH (0.15 mL) in CH2Cl2 (2.55 mL) 
under an inert atmosphere. It was then allowed to attain room temperature where it 
was left to stand for 1 h. The completion of the reactions was confirmed by TLC 
   34 
also using the solvent system L. Then, evaporation of volatiles to dryness, tritura-
tion with Et2O and cooling overnight provided the penta-trifluoroacetate salt of tox-
in Agel 416, following filtration and drying overnight under vacuo.  
 
Toxin HO-416b .5CF3CO2H. White solid; (76 mg, 70%); mp 225-226 oC; RP-
HPLC: tR = 15.73 min; 1H NMR (600 MHz, (CD3)2SO) δ 10.89 (br. s, 1H), 9.01 (br. 
s, 3H), 8.73 (br. s, 2H), 7.99 (br. s, 2H), 7.95 (t, J = 6.6 Hz, 1H), 7.53 (d, J = 7.7 Hz, 
1H), 7.34 (d, J = 7.7 Hz, 1H), 7.17 (unresolv. d, 1H), 7.06 (t, J = 7.7 Hz, 1H), 6.96 
(t, J = 7.7 Hz, 1H), 3.49 (s, 2H), 3.06 (q, J = 6.6 Hz, 2H), 3.02-2.96 (m, 8H), 2.94 (t, 
J = 7.8 Hz, 2H), 2.91-2.86 (m, 4H), 2.00-1.87 (m, 6H), 1.56 (quint., J = 7.2 Hz, 
2H), 1.44 (quint., J = 7.2 Hz, 2H) ppm; 13C{1H} NMR (150 MHz, (CD3)2SO) δ 
171.2, 159.0 (q, J = 31.5 Hz, 5C), 136.6, 127.7, 124.2, 121.4, 119.1, 118.7, 117.6 
(q, J = 297 Hz, 5C), 111.8, 109.3, 46.9, 45.4 (4C), 44.3, 38.4, 36.6, 33.2, 26.8, 24.3 
23.4, 22.9, 22.8 ppm; Anal. Calcd (%) for C33H45F15N6O11: C, 40.17; H, 4.60; N, 
8.52. Found: C, 40.24; H, 4.75; N, 8.66; MS (ESI, 30 eV): m/z 417.33 [M+H]+, 
209.19 [M+2H]2+.  
 
Toxin Agel 416 .5CF3CO2H. White solid (0.22 g, 73%); mp 199-201 oC; RP-HPLC: 
tR = 14.68 min; 1H NMR (600 MHz, (CD3)2SO) δ 10.90 (br. s, 1H), 8.89 and 8.73 
(two br. s, 7H), 8.08 (t, J = 6.6 Hz, 1H), 7.98 (br. s, 2H), 7.52 (d, J = 7.8 Hz, 1H), 
7.33 (d, J = 7.8 Hz, 1H), 7.18 (unresolv. d, 1H), 7.09-7.04 (m, 1H), 6.99-6.95 (m, 
1H), 3.50 (s, 2H), 3.11 (q, J = 6.6 Hz, 2H), 3.01-2.95 (m, 4H), 2.93-2.87 (m, 8H), 
2.83 (t, J = 6.6 Hz, 2H), 1.97-1.88 (m, 4H), 1.71 (quint., J = 7.2 Hz, 2H), 1.68-1.61 
(m, 4H) ppm; 13C{1H} NMR (150 MHz, (CD3)2SO) δ 171.9, 159.1 (q, J = 31.5 Hz, 
5C), 136.6, 127.6, 124.3, 121.4, 119.0, 118.8, 117.6 (q, J = 297 Hz, 5C), 111.9, 
109.1, 46.57, 46.56, 45.2, 44.4, 44.34, 44.32, 36.7, 36.2, 33.2, 26.5, 24.2, 23.10, 
23.08, 22.8 ppm; Anal Calcd. for C33H45F15N6O11: C, 40.17; H, 4.60; N, 8.52. 
Found: C, 40.19; H, 5.06; N, 8.58; MS (ESI, 30 eV): m/z 417.34 [M+H]+, 209.20 
[M+2H]2+. 
 
ASSOCIATED CONTENT 
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Supporting Information 1H- and 13C-NMR figures for synthesized compounds, 1H- 
and 13C-NMR as well as RP-HPLC chromatograms for final products (spider tox-
ins).  
 
AUTHOR INFORMATION 
  
Corresponding Author 
*Email: dapapaio@upatras.gr, Tel.: +30-2610-962954; Fax: +30-2610-962956 
 
ORCID 
Dionissios Papaioannou: 0000-0001-5845-4134 
Constantinos M. Athanassopoulos: 0000-0002-7549-1911 
Stefania Kalantzi: 0000-0001-5688-013X 
 
Authors contribution 
Conceptualization, D.P. Y.H.; Synthesis and characterization of compounds, S.K., 
C.M.A; Writing of Manuscript, S.K., D.P., C.M.A. and R.R.  
 
Notes 
The authors declare no competing financial interest.  
 
 
ACKNOWLEDGEMENTS 
We wish to thank the Financial Department of the University of Patras for funding 
part of this work. We are also grateful to Associate Professor T. Tselios, Chemistry 
Department, University of Patras, for the RP-HPLC chromatograms of the pen-
tafluoroacetate salts of spider toxins Agel 416 and HO-416b and Mr D. Vachliotis, 
Laboratory of Instrumental Analysis, University of Patras, for the NMR spectra and 
the Elemental Analyses. The authors would also like to thank the Unit of  Environ-
mental, Organic and Biochemical high resolution analysis-ORBITRAP-LC-MS of 
the University of Ioannina for providing access to the facilities. 
 
References 
   36 
1. Morgan, D. M. L. Polyamines: An Introduction. In Methods in Molecular 
Biology; Morgan, D. M. L., Ed.; Vol. 79: Polyamine protocols; Humana Press: New 
Jersey, 1998, 3-30.  
2. Karigiannis, G.; Papaioannou, D. Structure, Biological Activity and Synthesis of 
Polyamine Analogues and Conjugates. Eur. J. Org. Chem. 2000, 1841-1863. 
3. Hahn, F.; Schepers, U. Solid phase chemistry for the directed synthesis of 
biologically active polyamine analogs, derivatives, and conjugates. In 
Combinatorial Chemistry on Solid Supports; Bräse, S, Ed.; Top. Curr. Chem. 2007, 
278, 135-208. 
4. Jagu, E.; Pomel, S.; Pethe, S.; Loiseau, P. M.; Labruère, R. Polyamine-based 
analogs and conjugates as antikinetoplastid agents. Eur. J. Med. Chem. 2017, 139, 
982-1015. 
5. Wilson, D.; Boyle, G. M.; McIntyre, L.; Nolan, M. J.; Parsons, P. G.; Smith, J. J.; 
Tribolet, L.; Loukas, A.; Liddell, M. J.; Rash, L. D.; Daly, N. L. The aromatic head 
group of spider toxin polyamines influences toxicity to cancer cells, Toxins 2017, 9, 
346; doi:10.3390/toxins9110346. 
6. Hamana, K.; Nitsu, M.; Samejima, K.; Matsuzaki, S. Linear and branched 
pentaamines, hexaamines and heptaamines in seeds of Vicia sativa. Phytochemistry 
1991, 30 (10), 3319-3322. 
7. Takano, A.; Kakehi, J.-I.; Takahashi, T. Thermospermine is Not a Minor 
Polyamine in the Plant Kingdom. Plant Cell Physiol. 2012, 53 (4), 606-616. 
8. Milhinhos, A.; Prestele, J.; Bollhöner, B.; Matos, A.; Vera-Sirera, F.; Rambla, J. 
L.; Ljung, K.; Carbonell, J.; Blázquez, M. A.; Tuominen, H.; Miguel, C. M. 
Thermospermine levels are controlled by an auxin-dependent feedback loop 
mechanism in Populus xylem. Plant J. 2013, 75 (4), 685-698. 
9. Oshima, T. A New Polyamine, Thermospermine, 1,12-Diamino-4,8-diazado-
decane, from an Extreme Thermophile. J. Biol. Chem. 1979, 254, 8720─8722. 
10. Woster, P. M.; Casero Jr, R. A., Εds.; RSC Drug Discovery Series No. 17: 
Polyamine Drug Discovery, RSC Publishing, 2011. 
11. Melchiorre, C.; Bolognesi, M. L.; Minarini, A.; Rosini, M.; Tumiatti, V. 
Polyamines in drug discovery: From the universal template approach to the multi-
targeted ligand design strategy, J. Med. Chem. 2010, 53, 5906-5914. 
12. Jasys, V. J.; Kelbaugh, P. R.; Nason, D. M.; Phillips, D.; Rosnack, K. J.; 
Saccomano, N. A.; Stroh, J. G.; Volkmann, R. A.; Forman, J. T. Novel quaternary 
ammonium salt-containing polyamines from the Agelenopsis aperta funnel-web 
spider. J. Org. Chem. 1992, 57 (6), 1814-1820. 
13. Kalivretenos, A. G.; Nakanishi, K. Synthesis of philanthotoxin analogs with a 
branched polyamine moiety. J. Org. Chem. 1993, 58 (24), 6596-6608. 
14. Kuksa, V.; Buchan, R.; Kong Thoo Lin, P. Synthesis of Polyamines, Their 
Derivatives, Analogues, and Conjugates. Synthesis 2000, 1189-1207. 
   37 
15. Phanstiel; Price, H. L.; Wang, L.; Juusola, J.; Kline, M.; Shah, S. M. The Effect 
of Polyamine Homologation on the Transport and Cytotoxicity Properties of 
Polyamine−(DNA-Intercalator) Conjugates. J. Org. Chem. 2000, 65 (18), 5590-
5599. 
16. Andruszkiewicz, R.; Radowski, M.; Czajgucki, Z. Efficient synthesis of 
orthogonally protected spermidine and norspermidine derivatives, Synth. Commun. 
2005, 35, 1085-1094. 
17. Yingyongnarongkul, B.; Apiratikul, N.; Aroonrerk, N.; Suksamrarn, A. 
Synthesis of bis, tris and tetra(dihydrocaffeoyl)polyamine conjugates as 
antibacterial agents against VRSA, Arch. Pharm. Res. 2008, 31, 698-704.  
18. Skruber, K.; Chaplin, K. J.; Phanstiel IV, O. Synthesis and bioevaluation of 
macrocycle-polyamine conjugates as cell migration inhibitors, J. Med. Chem. 2017, 
60, 8606-8619. 
19. Borgini, M.; Orofino, F.; Truglio, G.; Balestri, L.; Botta, M. A gram-scale 
synthesis of a macrocyclic amidinourea with strong antifungal activity through a 
Fukuyama tri-protected polyamine intermediate. Arkivoc 2019, Part (iv), 168-177. 
20. Geall, A. J.; Blagbrough, I. S. Homologation of polyamines in the synthesis of 
lipo-spermine conjugates and related lipoplexes. Tetrahedron Lett. 1998, 39 (5), 
443-446. 
21. Chantrapromma, K.; McManis, J. S.; Ganem, B. The chemistry of naturally 
occurring polyamines. A total synthesis of thermospermine. Tetrahedron Lett. 1980, 
21 (26), 2475-2476. 
22. Kariya, Y.; Asanuma, Y.; Inai, M.; Asakawa, T.; Ohashi-Ito, K.; Fukuda, H.; 
Egi, M.; Kan, T. Practical Synthesis of Spermine, Thermospermine and 
Norspermine. Chem. Pharm. Bull. 2016, 64 (9), 1403-1407. 
23. Fukuyama, T.; Jow, C.-K.; Cheung, M. 2- and 4-Nitrobenzenesulfonamides: 
Exceptionally versatile means for preparation of secondary amines and protection of 
amines. Tetrahedron Lett. 1995, 36 (36), 6373-6374. 
24. Kan, T.; Fukuyama, T. Ns strategies: a highly versatile synthetic method for 
amines. Chem. Commun. 2004,  (4), 353-359. 
25. Hone, N. D.; Payne, L. J. Solid-phase synthesis of Agel 416; a novel approach 
to modifed polyamines. Tetrahedron Lett. 2000, 41, 6149-6152. 
26. Kellam, B.; Bycroft, B. W.; Chhabra, S. R. Solid phase applications of Dde and 
the analogue Nde: Synthesis of trypanothione disulphide. Tetrahedron Lett. 1997, 
38 (27), 4849-4852. 
27. Hidai, Y.; Kan, T.; Fukuyama, T. Total synthesis of polyamine toxin HO-416b 
utilizing the 2-nitrobenzenesulfonamide protecting group. Tetrahedron Lett. 1999, 
40 (25), 4711-4714. 
28. Magoulas, G. E.; Garnelis, T.; Athanassopoulos, C. M.; Papaioannou, D.; 
Mattheolabakis, G.; Avgoustakis, K.; Hadjipavlou-Litina, D. Synthesis and 
   38 
antioxidative/anti-inflammatory activity of novel fullerene–polyamine conjugates. 
Tetrahedron 2012, 68 (35), 7041-7049. 
29. Magoulas, G.; Bariamis, S.; Athanassopoulos, C.; Papaioannou, D. Synthetic 
studies toward the development of novel minoxidil analogs and conjugates with 
polyamines. Tetrahedron Lett. 2010, 51 (15), 1989-1993. 
30. Barlos, K.; Papaioannou, D.; Theodoropoulos, D. Efficient "one-pot" synthesis 
of N-tritylamino acids. J. Org. Chem. 1982, 47 (7), 1324-1326. 
31. Jasys, V. J.; Kelbaugh, P. R.; Nason, D. M.; Phillips, D.; Rosnack, K. J.; 
Saccomano, N. A.; Stroh, J. G.; Volkmann, R. A. Isolation, structure elucidation, 
and synthesis of novel hydroxylamine-containing polyamines from the venom of the 
Agelenopsis aperta spider. J. Am. Chem. Soc. 1990, 112, 6696-6704. 
 
 
 
 
 
